DB02083,"N,N-dimethylglycine",1118-68-9,experimental,FFDGPVCHZBVARC-UHFFFAOYSA-N,"InChI=1S/C4H9NO2/c1-5(2)3-4(6)7/h3H2,1-2H3,(H,6,7)",CN(C)CC(O)=O,C4H9NO2,C01026,,673.0,46507083.0,58251.0,,DMG,653.0,,FFDGPVCHZBVARC,176,673.0,dimethylglycine,,FFDGPVCHZBVARC-UHFFFAOYSA-N
DB01067,Glipizide,29094-61-9,approved; investigational,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,"InChI=1S/C21H27N5O4S/c1-15-13-24-19(14-23-15)20(27)22-12-11-16-7-9-18(10-8-16)31(29,30)26-21(28)25-17-5-3-2-4-6-17/h7-10,13-14,17H,2-6,11-12H2,1H3,(H,22,27)(H2,25,26,28)",CC1=NC=C(N=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1,C21H27N5O4S,,D00335,3478.0,46505865.0,5384.0,CHEMBL1073,,3359.0,50012956.0,ZJJXGWJIGJFDTL,344,3478.0,Glipizide,Hypoglycemic Agents;Chemical Actions and Uses;Pharmacologic Actions;Physiological Effects of Drugs,ZJJXGWJIGJFDTL-UHFFFAOYSA-N
DB08809,Dichloroacetic Acid,79-43-6,approved; investigational,JXTHNDFMNIQAHM-UHFFFAOYSA-N,"InChI=1S/C2H2Cl2O2/c3-1(4)2(5)6/h1H,(H,5,6)",OC(=O)C(Cl)Cl,C2H2Cl2O2,C11149,,6597.0,175427097.0,36386.0,CHEMBL13960,TF4,10771217.0,227588.0,JXTHNDFMNIQAHM,331,6597.0,Dichloroacetic Acid,,JXTHNDFMNIQAHM-UHFFFAOYSA-N
DB02123,Glycochenodeoxycholic Acid,640-79-9,experimental,GHCZAUBVMUEKKP-GYPHWSFCSA-N,"InChI=1S/C26H43NO5/c1-15(4-7-22(30)27-14-23(31)32)18-5-6-19-24-20(9-11-26(18,19)3)25(2)10-8-17(28)12-16(25)13-21(24)29/h15-21,24,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32)/t15-,16+,17-,18-,19+,20+,21-,24+,25+,26-/m1/s1",C[C@H](CCC(=O)NCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C26H43NO5,C05466,,12544.0,46506300.0,36274.0,CHEMBL1552,CHO,12027.0,50375590.0,GHCZAUBVMUEKKP,341,12544.0,Glycochenodeoxycholic Acid,Specialty Uses of Chemicals;Surface-Active Agents;Detergents;Chemical Actions and Uses,GHCZAUBVMUEKKP-GYPHWSFCSA-N
DB02994,Cacodylic acid,75-60-5,experimental,OGGXGZAMXPVRFZ-UHFFFAOYSA-N,"InChI=1S/C2H7AsO2/c1-3(2,4)5/h1-2H3,(H,4,5)",C[As](C)(O)=O,C2H7AsO2,C07308,,2513.0,46507712.0,48765.0,CHEMBL1231644,CAD,2418.0,,OGGXGZAMXPVRFZ,122,2513.0,Cacodylic Acid,Agrochemicals;Specialty Uses of Chemicals;Toxic Actions;Pesticides;Herbicides;Chemical Actions and Uses,OGGXGZAMXPVRFZ-UHFFFAOYSA-N
DB00262,Carmustine,154-93-8,approved; investigational,DLGOEMSEDOSKAD-UHFFFAOYSA-N,"InChI=1S/C5H9Cl2N3O2/c6-1-3-8-5(11)10(9-12)4-2-7/h1-4H2,(H,8,11)",ClCCNC(=O)N(CCCl)N=O,C5H9Cl2N3O2,C06873,D00254,2578.0,46506980.0,3423.0,CHEMBL513,,2480.0,50015950.0,DLGOEMSEDOSKAD,355,2578.0,Carmustine,"Toxic Actions;Antineoplastic Agents, Alkylating;Pharmacologic Actions;Antineoplastic Agents;Molecular Mechanisms of Pharmacological Action;Noxae;Alkylating Agents;Chemical Actions and Uses;Therapeutic Uses",DLGOEMSEDOSKAD-UHFFFAOYSA-N
DB03106,scyllo-inositol,488-59-5,investigational,CDAISMWEOUEBRE-CDRYSYESSA-N,"InChI=1S/C6H12O6/c7-1-2(8)4(10)6(12)5(11)3(1)9/h1-12H/t1-,2-,3+,4+,5-,6-",O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,C6H12O6,C06153,,892.0,46505198.0,10642.0,CHEMBL468154,2H3,10254646.0,,CDAISMWEOUEBRE,98,892.0,scyllitol,,CDAISMWEOUEBRE-UHFFFAOYSA-N
DB02731,Ethylmercurithiosalicylic acid,148-61-8,experimental,HXQVQGWHFRNKMS-UHFFFAOYSA-M,"InChI=1S/C7H6O2S.C2H5.Hg/c8-7(9)5-3-1-2-4-6(5)10;1-2;/h1-4,10H,(H,8,9);1H2,2H3;/q;;+1/p-1",CC[Hg]SC1=CC=CC=C1C(O)=O,C9H10HgO2S,,,67361.0,46506518.0,33214.0,,EMT,60691.0,50366032.0,HXQVQGWHFRNKMS,64,5441.0,,,HXQVQGWHFRNKMS-UHFFFAOYSA-L
DB02083,"N,N-dimethylglycine",1118-68-9,experimental,FFDGPVCHZBVARC-UHFFFAOYSA-N,"InChI=1S/C4H9NO2/c1-5(2)3-4(6)7/h3H2,1-2H3,(H,6,7)",CN(C)CC(O)=O,C4H9NO2,C01026,,673.0,46507083.0,58251.0,,DMG,653.0,,FFDGPVCHZBVARC,1138,673.0,dimethylglycine,,FFDGPVCHZBVARC-UHFFFAOYSA-N
DB08348,"N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",,experimental,UYJZZVDLGDDTCL-UHFFFAOYSA-N,"InChI=1S/C17H17N3O2/c1-20(2)10-16(21)18-11-7-8-15-14(9-11)12-5-3-4-6-13(12)17(22)19-15/h3-9H,10H2,1-2H3,(H,18,21)(H,19,22)",CN(C)CC(=O)NC1=CC2=C(NC(=O)C3=CC=CC=C23)C=C1,C17H17N3O2,,,4858.0,99444819.0,,CHEMBL372303,P34,4692.0,27497.0,UYJZZVDLGDDTCL,499,4858.0,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",,UYJZZVDLGDDTCL-UHFFFAOYSA-N
DB03109,N-Acetyl-D-Allosamine,,experimental,OVRNDRQMDRJTHS-UIAUGNHASA-N,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7+,8-/m1/s1",[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@@]([H])(O)[C@@]1([H])N=C(C)O,C8H15NO6,,,445246.0,46505390.0,,,NAA,392939.0,,OVRNDRQMDRJTHS,702,439174.0,Acetylglucosamine,,OVRNDRQMDRJTHS-RTRLPJTCSA-N
DB01452,Diamorphine,561-27-3,approved; illicit; investigational,GVGLGOZIDCSQPN-PVHGPHFFSA-N,"InChI=1S/C21H23NO5/c1-11(23)25-16-6-4-13-10-15-14-5-7-17(26-12(2)24)20-21(14,8-9-22(15)3)18(13)19(16)27-20/h4-7,14-15,17,20H,8-10H2,1-3H3/t14-,15+,17-,20-,21-/m0/s1",[H][C@@]12C=C[C@H](OC(C)=O)[C@@H]3OC4=C(OC(C)=O)C=CC5=C4[C@]13CCN(C)[C@@H]2C5,C21H23NO5,C06534,D07286,5462328.0,46506839.0,27808.0,CHEMBL459324,,4575379.0,,GVGLGOZIDCSQPN,1156,3592.0,,,GVGLGOZIDCSQPN-UHFFFAOYSA-N
DB02594,2'-Deoxycytidine,951-77-9,experimental; investigational,CKTSBUTUHBMZGZ-SHYZEUOFSA-N,"InChI=1S/C9H13N3O4/c10-7-1-2-12(9(15)11-7)8-3-5(14)6(4-13)16-8/h1-2,5-6,8,13-14H,3-4H2,(H2,10,11,15)/t5-,6+,8+/m0/s1",NC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](CO)O1,C9H13N3O4,C00881,,13711.0,46508326.0,15698.0,CHEMBL66115,DCZ,13117.0,50367094.0,CKTSBUTUHBMZGZ,293,44721303.0,,,CKTSBUTUHBMZGZ-OHEWIBQUSA-N
DB03967,Dodecyl sulfate,151-41-7,experimental,MOTZDAYCYVMXPC-UHFFFAOYSA-N,"InChI=1S/C12H26O4S/c1-2-3-4-5-6-7-8-9-10-11-12-16-17(13,14)15/h2-12H2,1H3,(H,13,14,15)",CCCCCCCCCCCCOS(O)(=O)=O,C12H26O4S,,,8778.0,46507629.0,45599.0,,SDS,8448.0,,MOTZDAYCYVMXPC,1279,8778.0,dodecyl sulfate,Chemical Actions and Uses;Specialty Uses of Chemicals;Surface-Active Agents,MOTZDAYCYVMXPC-UHFFFAOYSA-N
DB09220,Nicorandil,65141-46-0,approved; investigational,LBHIOVVIQHSOQN-UHFFFAOYSA-N,"InChI=1S/C8H9N3O4/c12-8(7-2-1-3-9-6-7)10-4-5-15-11(13)14/h1-3,6H,4-5H2,(H,10,12)",[O-][N+](=O)OCCNC(=O)C1=CC=CN=C1,C8H9N3O4,C13280,D01810,47528.0,310265127.0,31905.0,CHEMBL284906,,43240.0,,LBHIOVVIQHSOQN,793,47528.0,Nicorandil,Chemical Actions and Uses;Vitamins;Antihypertensive Agents;Therapeutic Uses;Micronutrients;Growth Substances;Nutrients;Anti-Arrhythmia Agents;Pharmacologic Actions;Vasodilator Agents;Vitamin B Complex;Physiological Effects of Drugs;Cardiovascular Agents,LBHIOVVIQHSOQN-UHFFFAOYSA-N
DB03989,D-Allopyranose,2595-97-3,experimental,WQZGKKKJIJFFOK-IVMDWMLBSA-N,"InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4-,5-,6?/m1/s1",OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O,C6H12O6,C01487,,439507.0,46505989.0,4093.0,CHEMBL1222152,ALL,388604.0,,WQZGKKKJIJFFOK,1444,439357.0,SHU 508,Chemical Actions and Uses;Contrast Media;Diagnostic Uses of Chemicals;Pharmacologic Actions;Specialty Uses of Chemicals,WQZGKKKJIJFFOK-PHYPRBDBSA-N
DB02123,Glycochenodeoxycholic Acid,640-79-9,experimental,GHCZAUBVMUEKKP-GYPHWSFCSA-N,"InChI=1S/C26H43NO5/c1-15(4-7-22(30)27-14-23(31)32)18-5-6-19-24-20(9-11-26(18,19)3)25(2)10-8-17(28)12-16(25)13-21(24)29/h15-21,24,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32)/t15-,16+,17-,18-,19+,20+,21-,24+,25+,26-/m1/s1",C[C@H](CCC(=O)NCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C26H43NO5,C05466,,12544.0,46506300.0,36274.0,CHEMBL1552,CHO,12027.0,50375590.0,GHCZAUBVMUEKKP,2,12544.0,Glycochenodeoxycholic Acid,Specialty Uses of Chemicals;Surface-Active Agents;Detergents;Chemical Actions and Uses,GHCZAUBVMUEKKP-GYPHWSFCSA-N
DB04398,Lactic Acid,50-21-5,approved; vet_approved,JVTAAEKCZFNVCJ-UHFFFAOYSA-N,"InChI=1S/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)",CC(O)C(O)=O,C3H6O3,C01432,D00111,612.0,46505582.0,78320.0,CHEMBL1200559,,592.0,23233.0,JVTAAEKCZFNVCJ,123,612.0,Lactic Acid,,JVTAAEKCZFNVCJ-UHFFFAOYSA-N
DB03652,beta-D-Galactopyranuronic acid,18968-14-4,experimental,AEMOLEFTQBMNLQ-DTEWXJGMSA-N,"InChI=1S/C6H10O7/c7-1-2(8)4(5(10)11)13-6(12)3(1)9/h1-4,6-9,12H,(H,10,11)/t1-,2+,3+,4-,6+/m0/s1",O[C@@H]1O[C@@H]([C@H](O)[C@H](O)[C@H]1O)C(O)=O,C6H10O7,C08348,,441476.0,46507499.0,47954.0,,GTR,390200.0,,AEMOLEFTQBMNLQ,647,445929.0,polygalacturonic acid,,AEMOLEFTQBMNLQ-BKBMJHBISA-N
DB01982,D-Mannuronic Acid,1986-14-7,experimental,AEMOLEFTQBMNLQ-BYHBOUFCSA-N,"InChI=1S/C6H10O7/c7-1-2(8)4(5(10)11)13-6(12)3(1)9/h1-4,6-9,12H,(H,10,11)/t1-,2-,3-,4-,6-/m0/s1",[H][C@]1(O)O[C@]([H])(C(O)=O)[C@@]([H])(O)[C@]([H])(O)[C@]1([H])O,C6H10O7,C02024,,657117.0,46506836.0,16224.0,,MAV,571317.0,,AEMOLEFTQBMNLQ,647,445929.0,polygalacturonic acid,,AEMOLEFTQBMNLQ-BKBMJHBISA-N
DB01980,Para-Iodo-D-Phenylalanine Hydroxamic Acid,,experimental,AJEPKWPHKPETBM-MRVPVSSYSA-N,"InChI=1S/C9H11IN2O2/c10-7-3-1-6(2-4-7)5-8(11)9(13)12-14/h1-4,8,14H,5,11H2,(H,12,13)/t8-/m1/s1",[H][C@@](N)(CC1=CC=C(I)C=C1)C(=O)NO,C9H11IN2O2,,,5288643.0,46507696.0,,,IPO,4450764.0,,AJEPKWPHKPETBM,113,4636047.0,,,AJEPKWPHKPETBM-UHFFFAOYSA-N
DB00120,L-Phenylalanine,63-91-2,approved; investigational; nutraceutical,COLNVLDHVKWLRT-QMMMGPOBSA-N,"InChI=1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)/t8-/m0/s1",N[C@@H](CC1=CC=CC=C1)C(O)=O,C9H11NO2,C00079,D00021,6140.0,46505708.0,17295.0,CHEMBL301523,PHE,5910.0,18073.0,COLNVLDHVKWLRT,1305,994.0,"1,2-dilauroylphosphatidic acid",,COLNVLDHVKWLRT-UHFFFAOYSA-N
DB02061,Cellobiose,528-50-7,experimental,GUBGYTABKSRVRQ-CUHNMECISA-N,"InChI=1S/C12H22O11/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17/h3-20H,1-2H2/t3-,4-,5-,6+,7-,8-,9-,10-,11?,12+/m1/s1",OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O,C12H22O11,C00185,,439178.0,46505046.0,17057.0,,CBI,388323.0,,GUBGYTABKSRVRQ,445,24802025.0,Cellulose,,GUBGYTABKSRVRQ-OMNYSSFVSA-N
DB01642,O1-Methyl-Glucose,7000-27-3,experimental,HOVAGTYPODGVJG-XUUWZHRGSA-N,"InChI=1S/C7H14O6/c1-12-7-6(11)5(10)4(9)3(2-8)13-7/h3-11H,2H2,1H3/t3-,4-,5+,6-,7-/m1/s1",CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C7H14O6,,,445238.0,46507087.0,320055.0,CHEMBL132186,MGL,392933.0,,HOVAGTYPODGVJG,693,2108.0,methylmannoside,,HOVAGTYPODGVJG-UHFFFAOYSA-N
DB03603,Glucaric acid,87-73-0,experimental,DSLZVSRJTYRBFB-LLEIAEIESA-N,"InChI=1S/C6H10O8/c7-1(3(9)5(11)12)2(8)4(10)6(13)14/h1-4,7-10H,(H,11,12)(H,13,14)/t1-,2-,3-,4+/m0/s1",O[C@@H]([C@H](O)[C@@H](O)C(O)=O)[C@H](O)C(O)=O,C6H10O8,C00767,,33037.0,46506906.0,16002.0,,GKR,30577.0,,DSLZVSRJTYRBFB,132,607.0,Glucaric Acid,,DSLZVSRJTYRBFB-UHFFFAOYSA-N
DB02644,N-Omega-Propyl-L-Arginine,,experimental,AOMXURITGZJPKB-ZETCQYMHSA-O,"InChI=1S/C9H20N4O2/c1-2-5-12-9(11)13-6-3-4-7(10)8(14)15/h7H,2-6,10H2,1H3,(H,14,15)(H3,11,12,13)/p+1/t7-/m0/s1",CCCNC(=[NH2+])NCCC[C@H](N)C(O)=O,C9H21N4O2,,,5287494.0,46507586.0,,,3AR,4449861.0,,AOMXURITGZJPKB,175,447180.0,N5-(imino(propylamino)methyl)ornithine,,AOMXURITGZJPKB-ZETCQYMHSA-N
DB03945,"N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium",3616-04-4,experimental,YHHSONZFOIEMCP-UHFFFAOYSA-O,"InChI=1S/C5H14NO4P/c1-6(2,3)4-5-10-11(7,8)9/h4-5H2,1-3H3,(H-,7,8,9)/p+1",C[N+](C)(C)CCOP(O)(O)=O,C5H15NO4P,C00588,,1014.0,46508785.0,18132.0,CHEMBL1235161,PC,989.0,,YHHSONZFOIEMCP,638,1014.0,Phosphorylcholine,,YHHSONZFOIEMCP-UHFFFAOYSA-O
DB00159,Icosapent,10417-94-4,approved; nutraceutical,JAZBEHYOTPTENJ-JLNKQSITSA-N,"InChI=1S/C20H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h3-4,6-7,9-10,12-13,15-16H,2,5,8,11,14,17-19H2,1H3,(H,21,22)/b4-3-,7-6-,10-9-,13-12-,16-15-",CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O,C20H30O2,C06428,D08061,446284.0,46506267.0,28364.0,CHEMBL460026,EPA,393682.0,50242349.0,JAZBEHYOTPTENJ,552,446284.0,Eicosapentaenoic Acid,,JAZBEHYOTPTENJ-JLNKQSITSA-N
DB08264,"(1R, 2S)-cis 1,2 dihydroxy-1,2-dihydronaphthalene",,experimental,QPUHWUSUBHNZCG-VHSXEESVSA-N,"InChI=1S/C10H10O2/c11-9-6-5-7-3-1-2-4-8(7)10(9)12/h1-6,9-12H/t9-,10+/m0/s1",[H][C@]1(O)C=CC2=C(C=CC=C2)[C@@]1([H])O,C10H10O2,C04314,,440294.0,99444735.0,44343.0,,NDH,389268.0,,QPUHWUSUBHNZCG,989,362.0,"1,2-dihydroxy-1,2-dihydronaphthalene",,QPUHWUSUBHNZCG-UHFFFAOYSA-N
DB04242,P-Hydroxybenzoic Acid,,experimental,FJKROLUGYXJWQN-UHFFFAOYSA-N,"InChI=1S/C7H6O3/c8-6-3-1-5(2-4-6)7(9)10/h1-4,8H,(H,9,10)",OC(=O)C1=CC=C(O)C=C1,C7H6O3,C00156,,135.0,46504662.0,30763.0,CHEMBL441343,PHB,132.0,26194.0,FJKROLUGYXJWQN,973,135.0,4-hydroxybenzoic acid,,FJKROLUGYXJWQN-UHFFFAOYSA-N
DB02083,"N,N-dimethylglycine",1118-68-9,experimental,FFDGPVCHZBVARC-UHFFFAOYSA-N,"InChI=1S/C4H9NO2/c1-5(2)3-4(6)7/h3H2,1-2H3,(H,6,7)",CN(C)CC(O)=O,C4H9NO2,C01026,,673.0,46507083.0,58251.0,,DMG,653.0,,FFDGPVCHZBVARC,291,673.0,dimethylglycine,,FFDGPVCHZBVARC-UHFFFAOYSA-N
DB01627,Lincomycin,154-21-2,approved; vet_approved,OJMMVQQUTAEWLP-KIDUDLJLSA-N,"InChI=1S/C18H34N2O6S/c1-5-6-10-7-11(20(3)8-10)17(25)19-12(9(2)21)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,21-24H,5-8H2,1-4H3,(H,19,25)/t9-,10-,11+,12-,13+,14-,15-,16-,18-/m1/s1",[H][C@](C)(O)[C@@]([H])(N=C(O)[C@]1([H])C[C@@]([H])(CCC)CN1C)[C@@]1([H])O[C@]([H])(SC)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O,C18H34N2O6S,C06812,D00223,3000540.0,46506668.0,6472.0,CHEMBL1447,3QB,2272112.0,50335522.0,OJMMVQQUTAEWLP,89,3928.0,Lincomycin,Pharmacologic Actions;Protein Synthesis Inhibitors;Anti-Infective Agents;Chemical Actions and Uses;Therapeutic Uses;Enzyme Inhibitors;Molecular Mechanisms of Pharmacological Action;Anti-Bacterial Agents,OJMMVQQUTAEWLP-UHFFFAOYSA-N
DB03142,Alpha-L-Arabinose,,experimental,HMFHBZSHGGEWLO-QMKXCQHVSA-N,"InChI=1S/C5H10O5/c6-1-2-3(7)4(8)5(9)10-2/h2-9H,1H2/t2-,3-,4+,5+/m0/s1",OC[C@@H]1O[C@@H](O)[C@H](O)[C@H]1O,C5H10O5,C02604,,445935.0,46508212.0,28772.0,,AHR,393416.0,,HMFHBZSHGGEWLO,44,11521105.0,,,HMFHBZSHGGEWLO-KKQCNMDGSA-N
DB03246,Beta-L-Arabinose,5328-37-0,experimental,HMFHBZSHGGEWLO-KLVWXMOXSA-N,"InChI=1S/C5H10O5/c6-1-2-3(7)4(8)5(9)10-2/h2-9H,1H2/t2-,3-,4+,5-/m0/s1",OC[C@@H]1O[C@H](O)[C@H](O)[C@H]1O,C5H10O5,C02479,,6857384.0,46506224.0,28272.0,,FUB,5256724.0,,HMFHBZSHGGEWLO,44,11521105.0,,,HMFHBZSHGGEWLO-KKQCNMDGSA-N
DB01369,Quinupristin,120138-50-3,approved,WTHRRGMBUAHGNI-LCYNINFDSA-N,"InChI=1S/C53H67N9O10S/c1-6-37-50(68)61-23-11-14-38(61)51(69)59(5)40(26-32-16-18-36(19-17-32)58(3)4)52(70)62-28-35(30-73-43-29-60-24-20-33(43)21-25-60)42(64)27-39(62)47(65)57-45(34-12-8-7-9-13-34)53(71)72-31(2)44(48(66)55-37)56-49(67)46-41(63)15-10-22-54-46/h7-10,12-13,15-19,22,31,33,35,37-40,43-45,63H,6,11,14,20-21,23-30H2,1-5H3,(H,55,66)(H,56,67)(H,57,65)/t31-,35+,37-,38+,39+,40+,43-,44+,45+/m1/s1",[H][C@@]12CCCN1C(=O)[C@@H](CC)NC(=O)[C@@H](NC(=O)C1=NC=CC=C1O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@]1([H])CC(=O)[C@]([H])(CS[C@@H]3CN4CCC3CC4)CN1C(=O)[C@H](CC1=CC=C(C=C1)N(C)C)N(C)C2=O)C1=CC=CC=C1,C53H67N9O10S,C08032,D00852,5388937.0,46505148.0,,CHEMBL1200649,,4470884.0,,WTHRRGMBUAHGNI,392,23724509.0,quinupristin,Therapeutic Uses;Chemical Actions and Uses;Anti-Infective Agents;Pharmacologic Actions;Anti-Bacterial Agents,WTHRRGMBUAHGNI-MJWHERSYSA-N
DB04293,7-(2-Amino-2-Phenyl-Acetylamino)-3-Chloro-8-Oxo-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,,experimental,JAPHQRWPEGVNBT-IJLUTSLNSA-N,"InChI=1S/C16H16ClN3O4/c17-9-6-7-10-12(15(22)20(10)13(9)16(23)24)19-14(21)11(18)8-4-2-1-3-5-8/h1-5,10-12H,6-7,18H2,(H,19,21)(H,23,24)/t10-,11-,12-/m1/s1",N[C@@H](C(=O)N[C@@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)C1=CC=CC=C1,C16H16ClN3O4,,,12897341.0,46507072.0,,CHEMBL3545874,LOR,26330257.0,,JAPHQRWPEGVNBT,398,3956.0,,,JAPHQRWPEGVNBT-UHFFFAOYSA-N
DB02123,Glycochenodeoxycholic Acid,640-79-9,experimental,GHCZAUBVMUEKKP-GYPHWSFCSA-N,"InChI=1S/C26H43NO5/c1-15(4-7-22(30)27-14-23(31)32)18-5-6-19-24-20(9-11-26(18,19)3)25(2)10-8-17(28)12-16(25)13-21(24)29/h15-21,24,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32)/t15-,16+,17-,18-,19+,20+,21-,24+,25+,26-/m1/s1",C[C@H](CCC(=O)NCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C26H43NO5,C05466,,12544.0,46506300.0,36274.0,CHEMBL1552,CHO,12027.0,50375590.0,GHCZAUBVMUEKKP,366,12544.0,Glycochenodeoxycholic Acid,Specialty Uses of Chemicals;Surface-Active Agents;Detergents;Chemical Actions and Uses,GHCZAUBVMUEKKP-GYPHWSFCSA-N
DB01606,Tazobactam,89786-04-9,approved,LPQZKKCYTLCDGQ-WEDXCCLWSA-N,"InChI=1S/C10H12N4O5S/c1-10(5-13-3-2-11-12-13)8(9(16)17)14-6(15)4-7(14)20(10,18)19/h2-3,7-8H,4-5H2,1H3,(H,16,17)/t7-,8+,10+/m1/s1",[H][C@@]12CC(=O)N1[C@@H](C(O)=O)[C@](C)(CN1C=CN=N1)S2(=O)=O,C10H12N4O5S,C07771,D00660,123630.0,46508088.0,9421.0,CHEMBL404,,110216.0,50053173.0,LPQZKKCYTLCDGQ,387,4836.0,,,LPQZKKCYTLCDGQ-UHFFFAOYSA-N
DB00731,Nateglinide,105816-04-4,approved; investigational,OELFLUMRDSZNSF-BRWVUGGUSA-N,"InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15-,16-,17-/m1/s1",[H][C@](CC1=CC=CC=C1)(N=C(O)[C@@]1([H])CC[C@@]([H])(CC1)C(C)C)C(O)=O,C19H27NO3,C12508,D01111,5311309.0,46504836.0,31897.0,CHEMBL783,,10482084.0,50344967.0,OELFLUMRDSZNSF,273,4443.0,,,OELFLUMRDSZNSF-UHFFFAOYSA-N
DB03608,Diminazene,536-71-0,experimental,XNYZHCFCZNMTFY-UHFFFAOYSA-N,"InChI=1S/C14H15N7/c15-13(16)9-1-5-11(6-2-9)19-21-20-12-7-3-10(4-8-12)14(17)18/h1-8H,(H3,15,16)(H3,17,18)(H,19,20)",NC(=N)C1=CC=C(N\N=N\C2=CC=C(C=C2)C(N)=N)C=C1,C14H15N7,C18388,,2354.0,46504758.0,81724.0,CHEMBL35241,BRN,2264.0,50000999.0,XNYZHCFCZNMTFY,756,2354.0,Diminazene,Antiprotozoal Agents;Pharmacologic Actions;Anti-Infective Agents;Chemical Actions and Uses;Trypanocidal Agents;Antiparasitic Agents;Therapeutic Uses,XNYZHCFCZNMTFY-UHFFFAOYSA-N
DB05327,Ranirestat,147254-64-6,investigational,QCVNMNYRNIMDKV-QGZVFWFLSA-N,"InChI=1S/C17H11BrFN3O4/c18-10-4-3-9(11(19)6-10)8-21-14(24)12-2-1-5-22(12)17(16(21)26)7-13(23)20-15(17)25/h1-6H,7-8H2,(H,20,23,25)/t17-/m1/s1",FC1=C(CN2C(=O)C3=CC=CN3[C@@]3(CC(=O)NC3=O)C2=O)C=CC(Br)=C1,C17H11BrFN3O4,,,153948.0,175426978.0,,CHEMBL334830,,135685.0,50067407.0,QCVNMNYRNIMDKV,379,9953887.0,,,QCVNMNYRNIMDKV-UHFFFAOYSA-N
DB03640,Beta-Hydroxyaspartic Acid,,experimental,YYLQUHNPNCGKJQ-NHYDCYSISA-N,"InChI=1S/C4H7NO5/c5-1(3(7)8)2(6)4(9)10/h1-2,6H,5H2,(H,7,8)(H,9,10)/t1-,2+/m0/s1",N[C@@H]([C@@H](O)C(O)=O)C(O)=O,C4H7NO5,C03961,,14463.0,46508333.0,17576.0,CHEMBL3317781,BH2,13809.0,,YYLQUHNPNCGKJQ,738,5425.0,3-hydroxyaspartic acid,,YYLQUHNPNCGKJQ-UHFFFAOYSA-N
DB01190,Clindamycin,18323-44-9,approved; vet_approved,KDLRVYVGXIQJDK-NOWPCOIGSA-N,"InChI=1S/C18H33ClN2O5S/c1-5-6-10-7-11(21(3)8-10)17(25)20-12(9(2)19)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,22-24H,5-8H2,1-4H3,(H,20,25)/t9?,10-,11+,12?,13+,14-,15-,16-,18-/m1/s1",CCC[C@@H]1C[C@H](N(C)C1)C(=O)NC(C(C)Cl)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O,C18H33ClN2O5S,C06914,D00277,446598.0,46506073.0,3745.0,CHEMBL376185,CLY,27005.0,,KDLRVYVGXIQJDK,415,29029.0,Clindamycin,Enzyme Inhibitors;Anti-Infective Agents;Pharmacologic Actions;Molecular Mechanisms of Pharmacological Action;Anti-Bacterial Agents;Chemical Actions and Uses;Protein Synthesis Inhibitors;Therapeutic Uses,KDLRVYVGXIQJDK-NOWPCOIGSA-N
DB01627,Lincomycin,154-21-2,approved; vet_approved,OJMMVQQUTAEWLP-KIDUDLJLSA-N,"InChI=1S/C18H34N2O6S/c1-5-6-10-7-11(20(3)8-10)17(25)19-12(9(2)21)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,21-24H,5-8H2,1-4H3,(H,19,25)/t9-,10-,11+,12-,13+,14-,15-,16-,18-/m1/s1",[H][C@](C)(O)[C@@]([H])(N=C(O)[C@]1([H])C[C@@]([H])(CCC)CN1C)[C@@]1([H])O[C@]([H])(SC)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O,C18H34N2O6S,C06812,D00223,3000540.0,46506668.0,6472.0,CHEMBL1447,3QB,2272112.0,50335522.0,OJMMVQQUTAEWLP,197,3928.0,Lincomycin,Pharmacologic Actions;Protein Synthesis Inhibitors;Anti-Infective Agents;Chemical Actions and Uses;Therapeutic Uses;Enzyme Inhibitors;Molecular Mechanisms of Pharmacological Action;Anti-Bacterial Agents,OJMMVQQUTAEWLP-UHFFFAOYSA-N
DB03142,Alpha-L-Arabinose,,experimental,HMFHBZSHGGEWLO-QMKXCQHVSA-N,"InChI=1S/C5H10O5/c6-1-2-3(7)4(8)5(9)10-2/h2-9H,1H2/t2-,3-,4+,5+/m0/s1",OC[C@@H]1O[C@@H](O)[C@H](O)[C@H]1O,C5H10O5,C02604,,445935.0,46508212.0,28772.0,,AHR,393416.0,,HMFHBZSHGGEWLO,0,11521105.0,,,HMFHBZSHGGEWLO-KKQCNMDGSA-N
DB03246,Beta-L-Arabinose,5328-37-0,experimental,HMFHBZSHGGEWLO-KLVWXMOXSA-N,"InChI=1S/C5H10O5/c6-1-2-3(7)4(8)5(9)10-2/h2-9H,1H2/t2-,3-,4+,5-/m0/s1",OC[C@@H]1O[C@H](O)[C@H](O)[C@H]1O,C5H10O5,C02479,,6857384.0,46506224.0,28272.0,,FUB,5256724.0,,HMFHBZSHGGEWLO,0,11521105.0,,,HMFHBZSHGGEWLO-KKQCNMDGSA-N
DB01369,Quinupristin,120138-50-3,approved,WTHRRGMBUAHGNI-LCYNINFDSA-N,"InChI=1S/C53H67N9O10S/c1-6-37-50(68)61-23-11-14-38(61)51(69)59(5)40(26-32-16-18-36(19-17-32)58(3)4)52(70)62-28-35(30-73-43-29-60-24-20-33(43)21-25-60)42(64)27-39(62)47(65)57-45(34-12-8-7-9-13-34)53(71)72-31(2)44(48(66)55-37)56-49(67)46-41(63)15-10-22-54-46/h7-10,12-13,15-19,22,31,33,35,37-40,43-45,63H,6,11,14,20-21,23-30H2,1-5H3,(H,55,66)(H,56,67)(H,57,65)/t31-,35+,37-,38+,39+,40+,43-,44+,45+/m1/s1",[H][C@@]12CCCN1C(=O)[C@@H](CC)NC(=O)[C@@H](NC(=O)C1=NC=CC=C1O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@]1([H])CC(=O)[C@]([H])(CS[C@@H]3CN4CCC3CC4)CN1C(=O)[C@H](CC1=CC=C(C=C1)N(C)C)N(C)C2=O)C1=CC=CC=C1,C53H67N9O10S,C08032,D00852,5388937.0,46505148.0,,CHEMBL1200649,,4470884.0,,WTHRRGMBUAHGNI,341,71338.0,quinupristin,Anti-Infective Agents;Chemical Actions and Uses;Therapeutic Uses;Anti-Bacterial Agents;Pharmacologic Actions,WTHRRGMBUAHGNI-UHFFFAOYSA-N
DB09220,Nicorandil,65141-46-0,approved; investigational,LBHIOVVIQHSOQN-UHFFFAOYSA-N,"InChI=1S/C8H9N3O4/c12-8(7-2-1-3-9-6-7)10-4-5-15-11(13)14/h1-3,6H,4-5H2,(H,10,12)",[O-][N+](=O)OCCNC(=O)C1=CC=CN=C1,C8H9N3O4,C13280,D01810,47528.0,310265127.0,31905.0,CHEMBL284906,,43240.0,,LBHIOVVIQHSOQN,272,47528.0,Nicorandil,Chemical Actions and Uses;Vitamins;Antihypertensive Agents;Therapeutic Uses;Micronutrients;Growth Substances;Nutrients;Anti-Arrhythmia Agents;Pharmacologic Actions;Vasodilator Agents;Vitamin B Complex;Physiological Effects of Drugs;Cardiovascular Agents,LBHIOVVIQHSOQN-UHFFFAOYSA-N
DB04293,7-(2-Amino-2-Phenyl-Acetylamino)-3-Chloro-8-Oxo-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,,experimental,JAPHQRWPEGVNBT-IJLUTSLNSA-N,"InChI=1S/C16H16ClN3O4/c17-9-6-7-10-12(15(22)20(10)13(9)16(23)24)19-14(21)11(18)8-4-2-1-3-5-8/h1-5,10-12H,6-7,18H2,(H,19,21)(H,23,24)/t10-,11-,12-/m1/s1",N[C@@H](C(=O)N[C@@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)C1=CC=CC=C1,C16H16ClN3O4,,,12897341.0,46507072.0,,CHEMBL3545874,LOR,26330257.0,,JAPHQRWPEGVNBT,504,3956.0,,,JAPHQRWPEGVNBT-UHFFFAOYSA-N
DB01606,Tazobactam,89786-04-9,approved,LPQZKKCYTLCDGQ-WEDXCCLWSA-N,"InChI=1S/C10H12N4O5S/c1-10(5-13-3-2-11-12-13)8(9(16)17)14-6(15)4-7(14)20(10,18)19/h2-3,7-8H,4-5H2,1H3,(H,16,17)/t7-,8+,10+/m1/s1",[H][C@@]12CC(=O)N1[C@@H](C(O)=O)[C@](C)(CN1C=CN=N1)S2(=O)=O,C10H12N4O5S,C07771,D00660,123630.0,46508088.0,9421.0,CHEMBL404,,110216.0,50053173.0,LPQZKKCYTLCDGQ,184,4836.0,,,LPQZKKCYTLCDGQ-UHFFFAOYSA-N
DB00731,Nateglinide,105816-04-4,approved; investigational,OELFLUMRDSZNSF-BRWVUGGUSA-N,"InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15-,16-,17-/m1/s1",[H][C@](CC1=CC=CC=C1)(N=C(O)[C@@]1([H])CC[C@@]([H])(CC1)C(C)C)C(O)=O,C19H27NO3,C12508,D01111,5311309.0,46504836.0,31897.0,CHEMBL783,,10482084.0,50344967.0,OELFLUMRDSZNSF,550,4443.0,,,OELFLUMRDSZNSF-UHFFFAOYSA-N
DB03608,Diminazene,536-71-0,experimental,XNYZHCFCZNMTFY-UHFFFAOYSA-N,"InChI=1S/C14H15N7/c15-13(16)9-1-5-11(6-2-9)19-21-20-12-7-3-10(4-8-12)14(17)18/h1-8H,(H3,15,16)(H3,17,18)(H,19,20)",NC(=N)C1=CC=C(N\N=N\C2=CC=C(C=C2)C(N)=N)C=C1,C14H15N7,C18388,,2354.0,46504758.0,81724.0,CHEMBL35241,BRN,2264.0,50000999.0,XNYZHCFCZNMTFY,221,2354.0,Diminazene,Antiprotozoal Agents;Pharmacologic Actions;Anti-Infective Agents;Chemical Actions and Uses;Trypanocidal Agents;Antiparasitic Agents;Therapeutic Uses,XNYZHCFCZNMTFY-UHFFFAOYSA-N
DB05327,Ranirestat,147254-64-6,investigational,QCVNMNYRNIMDKV-QGZVFWFLSA-N,"InChI=1S/C17H11BrFN3O4/c18-10-4-3-9(11(19)6-10)8-21-14(24)12-2-1-5-22(12)17(16(21)26)7-13(23)20-15(17)25/h1-6H,7-8H2,(H,20,23,25)/t17-/m1/s1",FC1=C(CN2C(=O)C3=CC=CN3[C@@]3(CC(=O)NC3=O)C2=O)C=CC(Br)=C1,C17H11BrFN3O4,,,153948.0,175426978.0,,CHEMBL334830,,135685.0,50067407.0,QCVNMNYRNIMDKV,261,153948.0,ranirestat,Chemical Actions and Uses;Enzyme Inhibitors;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions,QCVNMNYRNIMDKV-QGZVFWFLSA-N
DB03640,Beta-Hydroxyaspartic Acid,,experimental,YYLQUHNPNCGKJQ-NHYDCYSISA-N,"InChI=1S/C4H7NO5/c5-1(3(7)8)2(6)4(9)10/h1-2,6H,5H2,(H,7,8)(H,9,10)/t1-,2+/m0/s1",N[C@@H]([C@@H](O)C(O)=O)C(O)=O,C4H7NO5,C03961,,14463.0,46508333.0,17576.0,CHEMBL3317781,BH2,13809.0,,YYLQUHNPNCGKJQ,384,5425.0,3-hydroxyaspartic acid,,YYLQUHNPNCGKJQ-UHFFFAOYSA-N
DB01190,Clindamycin,18323-44-9,approved; vet_approved,KDLRVYVGXIQJDK-NOWPCOIGSA-N,"InChI=1S/C18H33ClN2O5S/c1-5-6-10-7-11(21(3)8-10)17(25)20-12(9(2)19)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,22-24H,5-8H2,1-4H3,(H,20,25)/t9?,10-,11+,12?,13+,14-,15-,16-,18-/m1/s1",CCC[C@@H]1C[C@H](N(C)C1)C(=O)NC(C(C)Cl)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O,C18H33ClN2O5S,C06914,D00277,446598.0,46506073.0,3745.0,CHEMBL376185,CLY,27005.0,,KDLRVYVGXIQJDK,78,29029.0,Clindamycin,Enzyme Inhibitors;Anti-Infective Agents;Pharmacologic Actions;Molecular Mechanisms of Pharmacological Action;Anti-Bacterial Agents;Chemical Actions and Uses;Protein Synthesis Inhibitors;Therapeutic Uses,KDLRVYVGXIQJDK-NOWPCOIGSA-N
DB02175,Malonic acid,141-82-2,experimental,OFOBLEOULBTSOW-UHFFFAOYSA-N,"InChI=1S/C3H4O4/c4-2(5)1-3(6)7/h1H2,(H,4,5)(H,6,7)",OC(=O)CC(O)=O,C3H4O4,C04025,,867.0,46504875.0,30794.0,CHEMBL7942,MLA,844.0,14673.0,OFOBLEOULBTSOW,1124,867.0,malonic acid,,OFOBLEOULBTSOW-UHFFFAOYSA-N
DB01252,Mitiglinide,145375-43-5,investigational,WPGGHFDDFPHPOB-BBWFWOEESA-N,"InChI=1S/C19H25NO3/c21-18(20-12-15-8-4-5-9-16(15)13-20)11-17(19(22)23)10-14-6-2-1-3-7-14/h1-3,6-7,15-17H,4-5,8-13H2,(H,22,23)/t15-,16+,17-/m0/s1",[H][C@@](CC(=O)N1C[C@@]2([H])CCCC[C@@]2([H])C1)(CC1=CC=CC=C1)C(O)=O,C19H25NO3,,D01854,121891.0,46506527.0,135349.0,CHEMBL471498,,108739.0,,WPGGHFDDFPHPOB,3443,121891.0,mitiglinide,Physiological Effects of Drugs;Hypoglycemic Agents;Pharmacologic Actions;Chemical Actions and Uses,WPGGHFDDFPHPOB-BBWFWOEESA-N
DB01251,Gliquidone,33342-05-1,approved; investigational,LLJFMFZYVVLQKT-UHFFFAOYSA-N,"InChI=1S/C27H33N3O6S/c1-27(2)23-14-11-20(36-3)17-22(23)24(31)30(25(27)32)16-15-18-9-12-21(13-10-18)37(34,35)29-26(33)28-19-7-5-4-6-8-19/h9-14,17,19H,4-8,15-16H2,1-3H3,(H2,28,29,33)",COC1=CC2=C(C=C1)C(C)(C)C(=O)N(CCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1)C2=O,C27H33N3O6S,,D02430,91610.0,46508425.0,93416.0,CHEMBL383634,,82719.0,,LLJFMFZYVVLQKT,156,91610.0,gliquidone,Pharmacologic Actions;Chemical Actions and Uses;Physiological Effects of Drugs;Hypoglycemic Agents,LLJFMFZYVVLQKT-UHFFFAOYSA-N
DB08168,7-AMINO-4-METHYL-CHROMEN-2-ONE,,experimental,GLNDAGDHSLMOKX-UHFFFAOYSA-N,"InChI=1S/C10H9NO2/c1-6-4-10(12)13-9-5-7(11)2-3-8(6)9/h2-5H,11H2,1H3",CC1=CC(=O)OC2=C1C=CC(N)=C2,C10H9NO2,C01386,,92249.0,99444639.0,51771.0,CHEMBL270672,MCM,83285.0,71742.0,GLNDAGDHSLMOKX,2601,92249.0,7-amino-4-methylcoumarin,Chemical Actions and Uses;Laboratory Chemicals;Specialty Uses of Chemicals;Indicators and Reagents,GLNDAGDHSLMOKX-UHFFFAOYSA-N
DB01896,M-Aminophenylboronic Acid,,experimental,JMZFEHDNIAQMNB-UHFFFAOYSA-N,"InChI=1S/C6H8BNO2/c8-6-3-1-2-5(4-6)7(9)10/h1-4,9-10H,8H2",NC1=CC=CC(=C1)B(O)O,C6H8BNO2,,,92269.0,46506000.0,,CHEMBL20852,APB,83303.0,50067906.0,JMZFEHDNIAQMNB,3665,92269.0,3-aminobenzeneboronic acid,,JMZFEHDNIAQMNB-UHFFFAOYSA-N
DB02553,Glutathionylspermidine Disulfide,,experimental,HCMZDPYSWPSKSP-XPGKHFPBSA-N,"InChI=1S/C34H66N12O10S2/c35-11-1-3-13-39-15-5-17-41-29(49)19-43-31(51)25(45-27(47)9-7-23(37)33(53)54)21-57-58-22-26(46-28(48)10-8-24(38)34(55)56)32(52)44-20-30(50)42-18-6-16-40-14-4-2-12-36/h23-26,39-40H,1-22,35-38H2,(H,41,49)(H,42,50)(H,43,51)(H,44,52)(H,45,47)(H,46,48)(H,53,54)(H,55,56)/t23-,24-,25+,26+/m1/s1",[H][C@@](N)(CCC(O)=N[C@@]([H])(CSSC[C@]([H])(N=C(O)CC[C@@]([H])(N)C(O)=O)C(O)=NCC(O)=NCCCNCCCCN)C(O)=NCC(O)=NCCCNCCCCN)C(O)=O,C34H66N12O10S2,,,449555.0,46505065.0,,,TS4,396047.0,,HCMZDPYSWPSKSP,2365,449555.0,,,HCMZDPYSWPSKSP-XPGKHFPBSA-N
DB03707,S-Ethyl-N-Phenyl-Isothiourea,,experimental,LAXNJIWNBHHMDO-UHFFFAOYSA-N,"InChI=1S/C9H12N2S/c1-2-12-9(10)11-8-6-4-3-5-7-8/h3-7H,2H2,1H3,(H2,10,11)",CCS\C(N)=N\C1=CC=CC=C1,C9H12N2S,,,347590.0,46506739.0,,CHEMBL451666,PTU,308438.0,50058459.0,LAXNJIWNBHHMDO,1643,347590.0,,,LAXNJIWNBHHMDO-UHFFFAOYSA-N
DB03953,L-Thiocitrulline,,experimental,BKGWACHYAMTLAF-BYPYZUCNSA-N,"InChI=1S/C6H13N3O2S/c7-4(5(10)11)2-1-3-9-6(8)12/h4H,1-3,7H2,(H,10,11)(H3,8,9,12)/t4-/m0/s1",N[C@@H](CCC\N=C(/N)S)C(O)=O,C6H13N3O2S,,,2733514.0,46505566.0,,CHEMBL93247,SCI,2015302.0,50095201.0,BKGWACHYAMTLAF,2951,2733514.0,,,BKGWACHYAMTLAF-BYPYZUCNSA-N
DB03310,Glutathione disulfide,27025-41-8,approved; experimental; investigational,YPZRWBKMTBYPTK-BJDJZHNGSA-N,"InChI=1S/C20H32N6O12S2/c21-9(19(35)36)1-3-13(27)25-11(17(33)23-5-15(29)30)7-39-40-8-12(18(34)24-6-16(31)32)26-14(28)4-2-10(22)20(37)38/h9-12H,1-8,21-22H2,(H,23,33)(H,24,34)(H,25,27)(H,26,28)(H,29,30)(H,31,32)(H,35,36)(H,37,38)/t9-,10-,11-,12-/m0/s1",N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O)C(=O)NCC(O)=O)C(O)=O,C20H32N6O12S2,C00127,D00031,65359.0,46508372.0,17858.0,CHEMBL1372,GDS,58835.0,225231.0,YPZRWBKMTBYPTK,3716,975.0,,,YPZRWBKMTBYPTK-UHFFFAOYSA-N
DB04509,N-Methylnaloxonium,,experimental,PCSQOABIHJXZMR-YNUHATHGSA-O,"InChI=1S/C20H23NO4/c1-3-9-21(2)10-8-19-16-12-4-5-13(22)17(16)25-18(19)14(23)6-7-20(19,24)15(21)11-12/h3-5,15,18,24H,1,6-11H2,2H3/p+1/t15-,18+,19+,20-,21-/m1/s1",C[N@@+]1(CC=C)CC[C@]23[C@H]4OC5=C(O)C=CC(C[C@@H]1[C@]2(O)CCC4=O)=C35,C20H24NO4,,,6323452.0,46508658.0,,,NLX,4883425.0,,PCSQOABIHJXZMR,326,6323452.0,,,PCSQOABIHJXZMR-YNUHATHGSA-O
DB03929,D-Serine,312-84-5,approved; experimental,MTCFGRXMJLQNBG-UWTATZPHSA-N,"InChI=1S/C3H7NO3/c4-2(1-5)3(6)7/h2,5H,1,4H2,(H,6,7)/t2-/m1/s1",N[C@H](CO)C(O)=O,C3H7NO3,C00740,,71077.0,46508200.0,16523.0,CHEMBL285123,DSN,64231.0,23167.0,MTCFGRXMJLQNBG,923,617.0,,,MTCFGRXMJLQNBG-UHFFFAOYSA-N
DB02132,Zenarestat,112733-06-9,experimental,SXONDGSPUVNZLO-UHFFFAOYSA-N,"InChI=1S/C17H11BrClFN2O4/c18-10-2-1-9(13(20)5-10)7-22-16(25)12-4-3-11(19)6-14(12)21(17(22)26)8-15(23)24/h1-6H,7-8H2,(H,23,24)",OC(=O)CN1C(=O)N(CC2=C(F)C=C(Br)C=C2)C(=O)C2=C1C=C(Cl)C=C2,C17H11BrClFN2O4,,,5724.0,46507491.0,,CHEMBL10413,ZES,5522.0,16496.0,SXONDGSPUVNZLO,2190,5724.0,FR 74366,Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Chemical Actions and Uses;Enzyme Inhibitors,SXONDGSPUVNZLO-UHFFFAOYSA-N
DB01211,Clarithromycin,81103-11-9,approved,AGOYDEPGAOXOCK-KCBOHYOISA-N,"InChI=1S/C38H69NO13/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1",[H][C@@]1(C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)O[C@H]1[C@H](C)[C@@H](O[C@]2([H])O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@@H]1C)OC,C38H69NO13,C06912,D00276,84029.0,46506489.0,3732.0,CHEMBL1741,CTY,10342604.0,50404044.0,AGOYDEPGAOXOCK,634,54688.0,,,AGOYDEPGAOXOCK-AVDMLEEESA-N
DB08231,Myristic acid,544-63-8,experimental,TUNFSRHWOTWDNC-UHFFFAOYSA-N,"InChI=1S/C14H28O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14(15)16/h2-13H2,1H3,(H,15,16)",CCCCCCCCCCCCCC(O)=O,C14H28O2,C06424,,11005.0,99444702.0,28875.0,CHEMBL111077,MYR,10539.0,50147581.0,TUNFSRHWOTWDNC,3139,11005.0,Myristic Acid,,TUNFSRHWOTWDNC-UHFFFAOYSA-N
DB03100,6-Nitroindazole,,experimental,ORZRMRUXSPNQQL-UHFFFAOYSA-N,"InChI=1S/C7H5N3O2/c11-10(12)6-2-1-5-4-8-9-7(5)3-6/h1-4H,(H,8,9)",O=N(=O)C1=CC2=NNC=C2C=C1,C7H5N3O2,,,24239.0,46504479.0,,CHEMBL54277,6NI,22661.0,50284964.0,ORZRMRUXSPNQQL,63,24239.0,6-nitroindazole,,ORZRMRUXSPNQQL-UHFFFAOYSA-N
DB02044,N-(3-(Aminomethyl)Benzyl)Acetamidine,,experimental,RODUKNYOEVZQPR-UHFFFAOYSA-N,"InChI=1S/C10H15N3/c1-8(12)13-7-10-4-2-3-9(5-10)6-11/h2-5H,6-7,11H2,1H3,(H2,12,13)",CC(=N)NCC1=CC=CC(CN)=C1,C10H15N3,,,1433.0,46507793.0,90721.0,CHEMBL107251,14W,1389.0,50065805.0,RODUKNYOEVZQPR,3133,1433.0,N-(3-(aminomethyl)benzyl)acetamidine,Enzyme Inhibitors;Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions,RODUKNYOEVZQPR-UHFFFAOYSA-N
DB02911,"2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine",,experimental,VEKRIXRQADJFAG-QMMMGPOBSA-N,"InChI=1S/C12H14N6/c13-10-9-11(18-12(14)17-10)15-6-8(16-9)7-4-2-1-3-5-7/h1-5,8,16H,6H2,(H5,13,14,15,17,18)/t8-/m0/s1",[H][C@]1(CNC2=C(N1)C(N)=NC(N)=N2)C1=CC=CC=C1,C12H14N6,,,445109.0,46504888.0,,,AP6,392845.0,,VEKRIXRQADJFAG,2555,445109.0,,,VEKRIXRQADJFAG-QMMMGPOBSA-N
DB04483,2-deoxy-2-fluoro-β-D-mannose,55449-80-4,experimental,ZCXUVYAZINUVJD-AIECOIEWSA-N,"InChI=1S/C6H11FO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1H2/t2-,3+,4-,5-,6-/m1/s1",OC[C@H]1O[C@@H](O)[C@@H](F)[C@@H](O)[C@@H]1O,C6H11FO5,,,445913.0,46507903.0,49152.0,CHEMBL1234222,MAF,393404.0,,ZCXUVYAZINUVJD,2688,5288324.0,,,ZCXUVYAZINUVJD-QZABAPFNSA-N
DB04084,2-deoxy-2-fluoro-α-D-mannose,62182-14-3,experimental,ZCXUVYAZINUVJD-RXRWUWDJSA-N,"InChI=1S/C6H11FO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1H2/t2-,3+,4-,5-,6+/m1/s1",OC[C@H]1O[C@H](O)[C@@H](F)[C@@H](O)[C@@H]1O,C6H11FO5,,,2758978.0,46506090.0,49148.0,,MBF,2039733.0,,ZCXUVYAZINUVJD,2688,5288324.0,,,ZCXUVYAZINUVJD-QZABAPFNSA-N
DB01627,Lincomycin,154-21-2,approved; vet_approved,OJMMVQQUTAEWLP-KIDUDLJLSA-N,"InChI=1S/C18H34N2O6S/c1-5-6-10-7-11(20(3)8-10)17(25)19-12(9(2)21)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,21-24H,5-8H2,1-4H3,(H,19,25)/t9-,10-,11+,12-,13+,14-,15-,16-,18-/m1/s1",[H][C@](C)(O)[C@@]([H])(N=C(O)[C@]1([H])C[C@@]([H])(CCC)CN1C)[C@@]1([H])O[C@]([H])(SC)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O,C18H34N2O6S,C06812,D00223,3000540.0,46506668.0,6472.0,CHEMBL1447,3QB,2272112.0,50335522.0,OJMMVQQUTAEWLP,1556,3928.0,Lincomycin,Pharmacologic Actions;Protein Synthesis Inhibitors;Anti-Infective Agents;Chemical Actions and Uses;Therapeutic Uses;Enzyme Inhibitors;Molecular Mechanisms of Pharmacological Action;Anti-Bacterial Agents,OJMMVQQUTAEWLP-UHFFFAOYSA-N
DB08653,2-(1H-INDOL-3-YL)ETHANAMINE,,experimental,APJYDQYYACXCRM-UHFFFAOYSA-N,"InChI=1S/C10H12N2/c11-6-5-8-7-12-10-4-2-1-3-9(8)10/h1-4,7,12H,5-6,11H2",NCCC1=CNC2=CC=CC=C12,C10H12N2,C00398,,1150.0,99445124.0,16765.0,CHEMBL6640,TSS,1118.0,50024210.0,APJYDQYYACXCRM,1799,1150.0,tryptamine,,APJYDQYYACXCRM-UHFFFAOYSA-N
DB00140,Riboflavin,83-88-5,approved; investigational; nutraceutical; vet_approved,AUNGANRZJHBGPY-SCRDCRAPSA-N,"InChI=1S/C17H20N4O6/c1-7-3-9-10(4-8(7)2)21(5-11(23)14(25)12(24)6-22)15-13(18-9)16(26)20-17(27)19-15/h3-4,11-12,14,22-25H,5-6H2,1-2H3,(H,20,26,27)/t11-,12+,14-/m0/s1",CC1=C(C)C=C2N(C[C@H](O)[C@H](O)[C@H](O)CO)C3=NC(=O)NC(=O)C3=NC2=C1,C17H20N4O6,C00255,D00050,493570.0,46507342.0,17015.0,CHEMBL1534,RBF,431981.0,50362895.0,AUNGANRZJHBGPY,2027,6759.0,,,AUNGANRZJHBGPY-MBNYWOFBSA-N
DB02462,Thiocoumarin,,experimental,DIOZFKOOIBATNZ-UHFFFAOYSA-N,"InChI=1S/C14H17NO2S/c1-15(2)8-5-9-17-12-10-14(16)18-13-7-4-3-6-11(12)13/h3-4,6-7,10H,5,8-9H2,1-2H3",CN(C)CCCOC1=CC(=O)SC2=CC=CC=C12,C14H17NO2S,,,657073.0,46508183.0,,,FC1,571284.0,,DIOZFKOOIBATNZ,2679,657073.0,,,DIOZFKOOIBATNZ-UHFFFAOYSA-N
DB02469,"4,6-dideoxy-4-amino-beta-D-glucopyranoside",,experimental,RJKBJEZZABBYBA-VFUOTHLCSA-N,"InChI=1S/C6H13NO4/c1-2-3(7)4(8)5(9)6(10)11-2/h2-6,8-10H,7H2,1H3/t2-,3-,4+,5-,6-/m1/s1",[H][C@]1(C)O[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])N,C6H13NO4,,,447845.0,46507559.0,,,DAG,394823.0,,RJKBJEZZABBYBA,1864,444139.0,,,RJKBJEZZABBYBA-DVKNGEFBSA-N
DB03144,N-Omega-Hydroxy-L-Arginine,,experimental,FQWRAVYMZULPNK-BYPYZUCNSA-N,"InChI=1S/C6H14N4O3/c7-4(5(11)12)2-1-3-9-6(8)10-13/h4,13H,1-3,7H2,(H,11,12)(H3,8,9,10)/t4-/m0/s1",N[C@@H](CCCNC(=N)NO)C(O)=O,C6H14N4O3,,,123895.0,46506099.0,43088.0,CHEMBL260629,HAR,110427.0,50230418.0,FQWRAVYMZULPNK,2579,123895.0,N(omega)-hydroxyarginine,,FQWRAVYMZULPNK-BYPYZUCNSA-N
DB03142,Alpha-L-Arabinose,,experimental,HMFHBZSHGGEWLO-QMKXCQHVSA-N,"InChI=1S/C5H10O5/c6-1-2-3(7)4(8)5(9)10-2/h2-9H,1H2/t2-,3-,4+,5+/m0/s1",OC[C@@H]1O[C@@H](O)[C@H](O)[C@H]1O,C5H10O5,C02604,,445935.0,46508212.0,28772.0,,AHR,393416.0,,HMFHBZSHGGEWLO,2219,11521105.0,,,HMFHBZSHGGEWLO-KKQCNMDGSA-N
DB03246,Beta-L-Arabinose,5328-37-0,experimental,HMFHBZSHGGEWLO-KLVWXMOXSA-N,"InChI=1S/C5H10O5/c6-1-2-3(7)4(8)5(9)10-2/h2-9H,1H2/t2-,3-,4+,5-/m0/s1",OC[C@@H]1O[C@H](O)[C@H](O)[C@H]1O,C5H10O5,C02479,,6857384.0,46506224.0,28272.0,,FUB,5256724.0,,HMFHBZSHGGEWLO,2219,11521105.0,,,HMFHBZSHGGEWLO-KKQCNMDGSA-N
DB03065,7-Nitroindazole-2-Carboxamidine,,experimental,GFYAZUABYOOPCN-UHFFFAOYSA-N,"InChI=1S/C8H7N5O2/c9-8(10)12-4-5-2-1-3-6(13(14)15)7(5)11-12/h1-4H,(H3,9,10)",NC(=N)N1C=C2C=CC=C(C2=N1)[N+]([O-])=O,C8H7N5O2,,,1894.0,46506294.0,,,7I2,1822.0,,GFYAZUABYOOPCN,657,1894.0,,,GFYAZUABYOOPCN-UHFFFAOYSA-N
DB01083,Orlistat,96829-58-2,approved; investigational,AHLBNYSZXLDEJQ-FWEHEUNISA-N,"InChI=1S/C29H53NO5/c1-5-7-9-11-12-13-14-15-16-18-24(34-29(33)26(30-22-31)20-23(3)4)21-27-25(28(32)35-27)19-17-10-8-6-2/h22-27H,5-21H2,1-4H3,(H,30,31)/t24-,25-,26-,27-/m0/s1",CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,C29H53NO5,,,3034010.0,46508309.0,94686.0,CHEMBL175247,,2298564.0,24567.0,AHLBNYSZXLDEJQ,1037,4599.0,,,AHLBNYSZXLDEJQ-UHFFFAOYSA-N
DB01369,Quinupristin,120138-50-3,approved,WTHRRGMBUAHGNI-LCYNINFDSA-N,"InChI=1S/C53H67N9O10S/c1-6-37-50(68)61-23-11-14-38(61)51(69)59(5)40(26-32-16-18-36(19-17-32)58(3)4)52(70)62-28-35(30-73-43-29-60-24-20-33(43)21-25-60)42(64)27-39(62)47(65)57-45(34-12-8-7-9-13-34)53(71)72-31(2)44(48(66)55-37)56-49(67)46-41(63)15-10-22-54-46/h7-10,12-13,15-19,22,31,33,35,37-40,43-45,63H,6,11,14,20-21,23-30H2,1-5H3,(H,55,66)(H,56,67)(H,57,65)/t31-,35+,37-,38+,39+,40+,43-,44+,45+/m1/s1",[H][C@@]12CCCN1C(=O)[C@@H](CC)NC(=O)[C@@H](NC(=O)C1=NC=CC=C1O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@]1([H])CC(=O)[C@]([H])(CS[C@@H]3CN4CCC3CC4)CN1C(=O)[C@H](CC1=CC=C(C=C1)N(C)C)N(C)C2=O)C1=CC=CC=C1,C53H67N9O10S,C08032,D00852,5388937.0,46505148.0,,CHEMBL1200649,,4470884.0,,WTHRRGMBUAHGNI,2336,71338.0,quinupristin,Anti-Infective Agents;Chemical Actions and Uses;Therapeutic Uses;Anti-Bacterial Agents;Pharmacologic Actions,WTHRRGMBUAHGNI-UHFFFAOYSA-N
DB01067,Glipizide,29094-61-9,approved; investigational,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,"InChI=1S/C21H27N5O4S/c1-15-13-24-19(14-23-15)20(27)22-12-11-16-7-9-18(10-8-16)31(29,30)26-21(28)25-17-5-3-2-4-6-17/h7-10,13-14,17H,2-6,11-12H2,1H3,(H,22,27)(H2,25,26,28)",CC1=NC=C(N=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1,C21H27N5O4S,,D00335,3478.0,46505865.0,5384.0,CHEMBL1073,,3359.0,50012956.0,ZJJXGWJIGJFDTL,36,3478.0,Glipizide,Hypoglycemic Agents;Chemical Actions and Uses;Pharmacologic Actions;Physiological Effects of Drugs,ZJJXGWJIGJFDTL-UHFFFAOYSA-N
DB08809,Dichloroacetic Acid,79-43-6,approved; investigational,JXTHNDFMNIQAHM-UHFFFAOYSA-N,"InChI=1S/C2H2Cl2O2/c3-1(4)2(5)6/h1H,(H,5,6)",OC(=O)C(Cl)Cl,C2H2Cl2O2,C11149,,6597.0,175427097.0,36386.0,CHEMBL13960,TF4,10771217.0,227588.0,JXTHNDFMNIQAHM,300,6597.0,Dichloroacetic Acid,,JXTHNDFMNIQAHM-UHFFFAOYSA-N
DB05448,PX-12,,investigational,BPBPYQWMFCTCNG-UHFFFAOYSA-N,"InChI=1S/C7H12N2S2/c1-3-6(2)10-11-7-8-4-5-9-7/h4-6H,3H2,1-2H3,(H,8,9)",CCC(C)SSC1=NC=CN1,C7H12N2S2,,,219104.0,175427007.0,94291.0,CHEMBL406050,,189920.0,50426071.0,BPBPYQWMFCTCNG,2775,219104.0,IV 2 compound,,BPBPYQWMFCTCNG-UHFFFAOYSA-N
DB02712,Sorbinil,68367-52-2,experimental; investigational,LXANPKRCLVQAOG-NSHDSACASA-N,"InChI=1S/C11H9FN2O3/c12-6-1-2-8-7(5-6)11(3-4-17-8)9(15)13-10(16)14-11/h1-2,5H,3-4H2,(H2,13,14,15,16)/t11-/m0/s1",FC1=CC=C2OCC[C@]3(NC(=O)NC3=O)C2=C1,C11H9FN2O3,,,337359.0,46504981.0,102029.0,CHEMBL266497,SBI,298991.0,16312.0,LXANPKRCLVQAOG,2425,5252.0,,,LXANPKRCLVQAOG-UHFFFAOYSA-N
DB02234,S-Ethylisothiourea,2986-20-1,experimental,VFIZBHJTOHUOEK-UHFFFAOYSA-N,"InChI=1S/C3H8N2S/c1-2-6-3(4)5/h2H2,1H3,(H3,4,5)",CCSC(N)=N,C3H8N2S,,,5139.0,46508006.0,,CHEMBL321691,ITU,4955.0,50055281.0,VFIZBHJTOHUOEK,1442,5139.0,etiron,Pharmacologic Actions;Central Nervous System Agents;Chemical Actions and Uses;Physiological Effects of Drugs;Therapeutic Uses;Molecular Mechanisms of Pharmacological Action;Enzyme Inhibitors;Cardiovascular Agents;Hypnotics and Sedatives;Vasoconstrictor Agents;Central Nervous System Depressants,VFIZBHJTOHUOEK-UHFFFAOYSA-N
DB02232,"1,2-Dihydroxybenzene",120-80-9,experimental,YCIMNLLNPGFGHC-UHFFFAOYSA-N,"InChI=1S/C6H6O2/c7-5-3-1-2-4-6(5)8/h1-4,7-8H",OC1=CC=CC=C1O,C6H6O2,C15571,,289.0,46507748.0,18135.0,CHEMBL280998,CAQ,13837760.0,26188.0,YCIMNLLNPGFGHC,1324,289.0,catechol,,YCIMNLLNPGFGHC-UHFFFAOYSA-N
DB04293,7-(2-Amino-2-Phenyl-Acetylamino)-3-Chloro-8-Oxo-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,,experimental,JAPHQRWPEGVNBT-IJLUTSLNSA-N,"InChI=1S/C16H16ClN3O4/c17-9-6-7-10-12(15(22)20(10)13(9)16(23)24)19-14(21)11(18)8-4-2-1-3-5-8/h1-5,10-12H,6-7,18H2,(H,19,21)(H,23,24)/t10-,11-,12-/m1/s1",N[C@@H](C(=O)N[C@@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)C1=CC=CC=C1,C16H16ClN3O4,,,12897341.0,46507072.0,,CHEMBL3545874,LOR,26330257.0,,JAPHQRWPEGVNBT,94,3956.0,,,JAPHQRWPEGVNBT-UHFFFAOYSA-N
DB03989,D-Allopyranose,2595-97-3,experimental,WQZGKKKJIJFFOK-IVMDWMLBSA-N,"InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4-,5-,6?/m1/s1",OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O,C6H12O6,C01487,,439507.0,46505989.0,4093.0,CHEMBL1222152,ALL,388604.0,,WQZGKKKJIJFFOK,1627,439680.0,"beta-1,4-mannan",,WQZGKKKJIJFFOK-RWOPYEJCSA-N
DB04534,5-Nitroindazole,,experimental,WSGURAYTCUVDQL-UHFFFAOYSA-N,"InChI=1S/C7H5N3O2/c11-10(12)6-1-2-7-5(3-6)4-8-9-7/h1-4H,(H,8,9)",O=N(=O)C1=CC=C2NN=CC2=C1,C7H5N3O2,,,21501.0,46505588.0,,CHEMBL165372,5NI,20208.0,50304144.0,WSGURAYTCUVDQL,1798,21501.0,5-nitroindazole,,WSGURAYTCUVDQL-UHFFFAOYSA-N
DB00912,Repaglinide,135062-02-1,approved; investigational,FAEKWTJYAYMJKF-QHCPKHFHSA-N,"InChI=1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1",CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)=C1)C(O)=O,C27H36N2O4,C07670,D00594,65981.0,46508150.0,8805.0,CHEMBL1272,,59377.0,50153520.0,FAEKWTJYAYMJKF,2362,65981.0,repaglinide,Pharmacologic Actions;Physiological Effects of Drugs;Hypoglycemic Agents;Chemical Actions and Uses,FAEKWTJYAYMJKF-QHCPKHFHSA-N
DB02994,Cacodylic acid,75-60-5,experimental,OGGXGZAMXPVRFZ-UHFFFAOYSA-N,"InChI=1S/C2H7AsO2/c1-3(2,4)5/h1-2H3,(H,4,5)",C[As](C)(O)=O,C2H7AsO2,C07308,,2513.0,46507712.0,48765.0,CHEMBL1231644,CAD,2418.0,,OGGXGZAMXPVRFZ,3394,2513.0,Cacodylic Acid,Agrochemicals;Specialty Uses of Chemicals;Toxic Actions;Pesticides;Herbicides;Chemical Actions and Uses,OGGXGZAMXPVRFZ-UHFFFAOYSA-N
DB02991,S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea,,experimental,LCMOXIFARISMOH-UHFFFAOYSA-N,"InChI=1S/C10H11F3N2S/c1-2-16-9(14)15-8-5-3-7(4-6-8)10(11,12)13/h3-6H,2H2,1H3,(H2,14,15)",CCS\C(N)=N\C1=CC=C(C=C1)C(F)(F)F,C10H11F3N2S,,,3311.0,46505446.0,,CHEMBL323542,TFM,3195.0,50058464.0,LCMOXIFARISMOH,1601,3311.0,S-ethyl N-(4-(trifluoromethyl)phenyl)isothiourea,,LCMOXIFARISMOH-UHFFFAOYSA-N
DB03056,4-Piperidino-Piperidine,,experimental,QDVBKXJMLILLLB-UHFFFAOYSA-N,"InChI=1S/C10H20N2/c1-2-8-12(9-3-1)10-4-6-11-7-5-10/h10-11H,1-9H2",C1CCN(CC1)C1CCNCC1,C10H20N2,,,78607.0,46507790.0,40117.0,CHEMBL174391,4PN,70964.0,50218206.0,QDVBKXJMLILLLB,708,78607.0,4-(1-piperidino)piperidine,,QDVBKXJMLILLLB-UHFFFAOYSA-N
DB02589,Se-Ethyl-Isoselenourea,,experimental,FFKYNFXDBBLWGF-UHFFFAOYSA-N,"InChI=1S/C3H8N2Se/c1-2-6-3(4)5/h2H2,1H3,(H3,4,5)",CC[Se]C(N)=N,C3H8N2Se,,,449633.0,46504841.0,,,ISU,396099.0,,FFKYNFXDBBLWGF,2363,449633.0,,,FFKYNFXDBBLWGF-UHFFFAOYSA-N
DB04018,S-Isopropyl-Isothiourea,,experimental,XSSNABKEYXKKMK-UHFFFAOYSA-N,"InChI=1S/C4H10N2S/c1-3(2)7-4(5)6/h3H,1-2H3,(H3,5,6)",CC(C)SC(N)=N,C4H10N2S,,,445319.0,46505190.0,,CHEMBL483091,IPU,392993.0,50271827.0,XSSNABKEYXKKMK,2162,445319.0,,,XSSNABKEYXKKMK-UHFFFAOYSA-N
DB04392,"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",,experimental,HIZKPJUTKKJDGA-BETUJISGSA-N,"InChI=1S/C19H12O6/c20-16-10-5-1-3-7-14(10)24-18(22)12(16)9-13-17(21)11-6-2-4-8-15(11)25-19(13)23/h1-8,12-13H,9H2/t12-,13+",[H][C@@]1(C[C@@]2([H])C(=O)OC3=C(C=CC=C3)C2=O)C(=O)OC2=CC=CC=C2C1=O,C19H12O6,,,17753965.0,46508476.0,,,DTC,16743957.0,,HIZKPJUTKKJDGA,723,17753965.0,,,HIZKPJUTKKJDGA-BETUJISGSA-N
DB00672,Chlorpropamide,94-20-2,approved; investigational,RKWGIWYCVPQPMF-UHFFFAOYSA-N,"InChI=1S/C10H13ClN2O3S/c1-2-7-12-10(14)13-17(15,16)9-5-3-8(11)4-6-9/h3-6H,2,7H2,1H3,(H2,12,13,14)",CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1,C10H13ClN2O3S,,D00271,2727.0,46506402.0,3650.0,CHEMBL498,,2626.0,50344965.0,RKWGIWYCVPQPMF,2457,2727.0,Chlorpropamide,Hypoglycemic Agents;Physiological Effects of Drugs;Pharmacologic Actions;Chemical Actions and Uses,RKWGIWYCVPQPMF-UHFFFAOYSA-N
DB03974,L-Homoarginine,,experimental,QUOGESRFPZDMMT-YFKPBYRVSA-N,"InChI=1S/C7H16N4O2/c8-5(6(12)13)3-1-2-4-11-7(9)10/h5H,1-4,8H2,(H,12,13)(H4,9,10,11)/t5-/m0/s1",N[C@@H](CCCCNC(N)=N)C(O)=O,C7H16N4O2,C01924,,9085.0,46506308.0,27747.0,CHEMBL589752,HRG,8732.0,50309588.0,QUOGESRFPZDMMT,751,9085.0,Homoarginine,,QUOGESRFPZDMMT-YFKPBYRVSA-N
DB03975,Mercuribenzoic Acid,,experimental,FVFZSVRSDNUCGG-UHFFFAOYSA-N,"InChI=1S/C7H5O2.Hg/c8-7(9)6-4-2-1-3-5-6;/h2-5H,(H,8,9);",OC(=O)C1=CC=C([Hg])C=C1,C7H5HgO2,,,8747.0,46507167.0,28886.0,,MBO,8417.0,,FVFZSVRSDNUCGG,481,8747.0,,,FVFZSVRSDNUCGG-UHFFFAOYSA-N
DB01800,"N,4-Dihydroxy-N-Oxo-3-(Sulfooxy)Benzenaminium",,experimental,XMCCOOONGGUOLA-UHFFFAOYSA-N,"InChI=1S/C6H5NO7S/c8-5-2-1-4(7(9)10)3-6(5)14-15(11,12)13/h1-3,8H,(H,11,12,13)",OC1=CC=C(C=C1OS(O)(=O)=O)[N+]([O-])=O,C6H5NO7S,,,165879.0,46505967.0,41733.0,,CSN,145373.0,,XMCCOOONGGUOLA,2892,165879.0,4-nitrocatechol sulfate,,XMCCOOONGGUOLA-UHFFFAOYSA-N
DB01997,3-Bromo-7-Nitroindazole,,experimental,NFSTZPMYAZRZPC-UHFFFAOYSA-N,"InChI=1S/C7H4BrN3O2/c8-7-4-2-1-3-5(11(12)13)6(4)9-10-7/h1-3H,(H,9,10)",BrC1=NNC2=C1C=CC=C2N(=O)=O,C7H4BrN3O2,,,1649.0,46507791.0,,CHEMBL479014,INE,1587.0,50270528.0,NFSTZPMYAZRZPC,1968,1649.0,3-bromo-7-nitroindazole,,NFSTZPMYAZRZPC-UHFFFAOYSA-N
DB08214,4-(1H-IMIDAZOL-1-YL)PHENOL,,experimental,CYKCUAPYWQDIKR-UHFFFAOYSA-N,"InChI=1S/C9H8N2O/c12-9-3-1-8(2-4-9)11-6-5-10-7-11/h1-7,12H",OC1=CC=C(C=C1)N1C=CN=C1,C9H8N2O,,,82315.0,99444685.0,,CHEMBL275339,MSR,74286.0,105193.0,CYKCUAPYWQDIKR,3627,82315.0,,,CYKCUAPYWQDIKR-UHFFFAOYSA-N
DB01689,Inhibitor Idd 384,,experimental,CJKKMQCZOLCXAM-UHFFFAOYSA-N,"InChI=1S/C19H22N2O5S/c1-12-6-4-5-7-15(12)10-17(22)21-16-8-13(2)19(14(3)9-16)27(25,26)20-11-18(23)24/h4-9,20H,10-11H2,1-3H3,(H,21,22)(H,23,24)",CC1=CC=CC=C1CC(=O)NC1=CC(C)=C(C(C)=C1)S(=O)(=O)NCC(O)=O,C19H22N2O5S,,,1944.0,46505474.0,,CHEMBL240719,I84,1868.0,50222612.0,CJKKMQCZOLCXAM,1678,1944.0,,,CJKKMQCZOLCXAM-UHFFFAOYSA-N
DB02335,2-Aminothiazoline,1779-81-3,experimental,REGFWZVTTFGQOJ-UHFFFAOYSA-N,"InChI=1S/C3H6N2S/c4-3-5-1-2-6-3/h1-2H2,(H2,4,5)",NC1=NCCS1,C3H6N2S,,,15689.0,46506807.0,40889.0,CHEMBL362148,ATQ,14923.0,50150920.0,REGFWZVTTFGQOJ,3645,15689.0,2-aminothiazoline,,REGFWZVTTFGQOJ-UHFFFAOYSA-N
DB01110,Miconazole,22916-47-8,approved; investigational; vet_approved,BYBLEWFAAKGYCD-UHFFFAOYSA-N,"InChI=1S/C18H14Cl4N2O/c19-13-2-1-12(16(21)7-13)10-25-18(9-24-6-5-23-11-24)15-4-3-14(20)8-17(15)22/h1-8,11,18H,9-10H2",ClC1=CC(Cl)=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1,C18H14Cl4N2O,C08070,D00882,4189.0,46506017.0,82892.0,CHEMBL91,,4044.0,31772.0,BYBLEWFAAKGYCD,3812,4189.0,Miconazole,"Metabolic Side Effects of Drugs and Substances;Steroid Synthesis Inhibitors;Therapeutic Uses;14-alpha Demethylase Inhibitors;Physiological Effects of Drugs;Cytochrome P-450 Enzyme Inhibitors;Enzyme Inhibitors;Molecular Mechanisms of Pharmacological Action;Antifungal Agents;Hormone Antagonists;Hormones, Hormone Substitutes, and Hormone Antagonists;Anti-Infective Agents;Chemical Actions and Uses;Pharmacologic Actions;Cytochrome P-450 CYP2C9 Inhibitors;Cytochrome P-450 CYP3A Inhibitors",BYBLEWFAAKGYCD-UHFFFAOYSA-N
DB02709,Resveratrol,501-36-0,approved; experimental; investigational,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,"InChI=1S/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1+",OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1,C14H12O3,C03582,,445154.0,46504705.0,45713.0,CHEMBL165,STL,392875.0,23926.0,LUKBXSAWLPMMSZ,841,46782864.0,,,LUKBXSAWLPMMSZ-OYESDQHJSA-N
DB08741,"5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine",,experimental,HWJPWWYTGBZDEG-AWEZNQCLSA-N,"InChI=1S/C19H22N4O3/c1-24-15-8-11(7-12-9-22-19(21)23-18(12)20)13-5-6-14(10-3-4-10)26-16(13)17(15)25-2/h5-6,8-10,14H,3-4,7H2,1-2H3,(H4,20,21,22,23)/t14-/m0/s1",[H][C@@]1(OC2=C(OC)C(OC)=CC(CC3=C(N)N=C(N)N=C3)=C2C=C1)C1CC1,C19H22N4O3,,,10247560.0,99445212.0,131752.0,CHEMBL1236788,XCF,8423047.0,50336513.0,HWJPWWYTGBZDEG,869,213043.0,iclaprim,Chemical Actions and Uses;Pharmacologic Actions;Folic Acid Antagonists;Enzyme Inhibitors;Molecular Mechanisms of Pharmacological Action,HWJPWWYTGBZDEG-UHFFFAOYSA-N
DB07938,"5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-chroman-5-yl]methyl]pyrimidine-2,4-diamine",,experimental,HWJPWWYTGBZDEG-CQSZACIVSA-N,"InChI=1S/C19H22N4O3/c1-24-15-8-11(7-12-9-22-19(21)23-18(12)20)13-5-6-14(10-3-4-10)26-16(13)17(15)25-2/h5-6,8-10,14H,3-4,7H2,1-2H3,(H4,20,21,22,23)/t14-/m1/s1",[H][C@]1(OC2=C(C=C1)C(CC1=CNC(=N)NC1=N)=CC(OC)=C2OC)C1CC1,C19H22N4O3,,,44141864.0,99444409.0,131753.0,CHEMBL1673303,I2H,,50336514.0,HWJPWWYTGBZDEG,869,213043.0,iclaprim,Chemical Actions and Uses;Pharmacologic Actions;Folic Acid Antagonists;Enzyme Inhibitors;Molecular Mechanisms of Pharmacological Action,HWJPWWYTGBZDEG-UHFFFAOYSA-N
DB02381,nor-NOHA,189302-40-7,investigational,KOBHCUDVWOTEKO-VKHMYHEASA-N,"InChI=1S/C5H12N4O3/c6-3(4(10)11)1-2-8-5(7)9-12/h3,12H,1-2,6H2,(H,10,11)(H3,7,8,9)/t3-/m0/s1",N[C@@H](CCNC(=N)NO)C(O)=O,C5H12N4O3,,,446124.0,46505343.0,,CHEMBL1234777,NNH,393563.0,50008099.0,KOBHCUDVWOTEKO,240,3253680.0,,,KOBHCUDVWOTEKO-UHFFFAOYSA-N
DB01606,Tazobactam,89786-04-9,approved,LPQZKKCYTLCDGQ-WEDXCCLWSA-N,"InChI=1S/C10H12N4O5S/c1-10(5-13-3-2-11-12-13)8(9(16)17)14-6(15)4-7(14)20(10,18)19/h2-3,7-8H,4-5H2,1H3,(H,16,17)/t7-,8+,10+/m1/s1",[H][C@@]12CC(=O)N1[C@@H](C(O)=O)[C@](C)(CN1C=CN=N1)S2(=O)=O,C10H12N4O5S,C07771,D00660,123630.0,46508088.0,9421.0,CHEMBL404,,110216.0,50053173.0,LPQZKKCYTLCDGQ,342,4836.0,,,LPQZKKCYTLCDGQ-UHFFFAOYSA-N
DB07139,3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid,,experimental,IHKCOKRMJRDWAL-UHFFFAOYSA-N,"InChI=1S/C13H11NO4S/c15-13(16)7-5-11-4-6-12(19-11)9-2-1-3-10(8-9)14(17)18/h1-4,6,8H,5,7H2,(H,15,16)",OC(=O)CCC1=CC=C(S1)C1=CC(=CC=C1)[N+]([O-])=O,C13H11NO4S,,,25210476.0,99443610.0,,,53N,25056818.0,,IHKCOKRMJRDWAL,1244,25210476.0,,,IHKCOKRMJRDWAL-UHFFFAOYSA-N
DB00731,Nateglinide,105816-04-4,approved; investigational,OELFLUMRDSZNSF-BRWVUGGUSA-N,"InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15-,16-,17-/m1/s1",[H][C@](CC1=CC=CC=C1)(N=C(O)[C@@]1([H])CC[C@@]([H])(CC1)C(C)C)C(O)=O,C19H27NO3,C12508,D01111,5311309.0,46504836.0,31897.0,CHEMBL783,,10482084.0,50344967.0,OELFLUMRDSZNSF,451,60026.0,,,OELFLUMRDSZNSF-JCYILVPMSA-N
DB05383,Pimagedine,79-17-4,investigational,HAMNKKUPIHEESI-UHFFFAOYSA-N,"InChI=1S/CH6N4/c2-1(3)5-4/h4H2,(H4,2,3,5)",NNC(N)=N,CH6N4,,,2146.0,175426990.0,40618.0,CHEMBL225304,AGU,2061.0,50207159.0,HAMNKKUPIHEESI,45,2146.0,pimagedine,Chemical Actions and Uses;Enzyme Inhibitors;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions,HAMNKKUPIHEESI-UHFFFAOYSA-N
DB04628,Allosamidin,103782-08-7,experimental,MDWNFWDBQGOKNZ-XYUDZHFQSA-N,"InChI=1S/C25H42N4O14/c1-8(33)26-14-17(36)16(35)11(6-31)39-23(14)42-22-12(7-32)40-24(15(19(22)38)27-9(2)34)41-21-10(5-30)20-13(18(21)37)28-25(43-20)29(3)4/h10-24,30-32,35-38H,5-7H2,1-4H3,(H,26,33)(H,27,34)/t10-,11+,12+,13+,14+,15+,16+,17-,18+,19-,20-,21+,22+,23-,24-/m0/s1",CN(C)C1=N[C@@H]2[C@@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@@H](O)[C@H]4NC(C)=O)[C@@H](O)[C@H]3NC(C)=O)[C@@H](CO)[C@@H]2O1,C25H42N4O14,C05346,,119339.0,46506500.0,,CHEMBL1230997,AO3,106593.0,50331851.0,MDWNFWDBQGOKNZ,112,119339.0,allosamidin,Agrochemicals;Molecular Mechanisms of Pharmacological Action;Chemical Actions and Uses;Specialty Uses of Chemicals;Toxic Actions;Pesticides;Insecticides;Pharmacologic Actions;Enzyme Inhibitors,MDWNFWDBQGOKNZ-XYUDZHFQSA-N
DB02207,7-Nitroindazole,2942-42-9,experimental,PQCAUHUKTBHUSA-UHFFFAOYSA-N,"InChI=1S/C7H5N3O2/c11-10(12)6-3-1-2-5-4-8-9-7(5)6/h1-4H,(H,8,9)",O=N(=O)C1=CC=CC2=CNN=C12,C7H5N3O2,,,1893.0,46504896.0,,CHEMBL247378,7NI,1821.0,50209245.0,PQCAUHUKTBHUSA,2353,1893.0,7-nitroindazole,Peripheral Nervous System Agents;Anticonvulsants;Anti-Anxiety Agents;Therapeutic Uses;Analgesics;Sensory System Agents;Central Nervous System Agents;Chemical Actions and Uses;Physiological Effects of Drugs;Protective Agents;Psychotropic Drugs;Pharmacologic Actions;Central Nervous System Depressants;Enzyme Inhibitors;Tranquilizing Agents;Molecular Mechanisms of Pharmacological Action;Neuroprotective Agents,PQCAUHUKTBHUSA-UHFFFAOYSA-N
DB00120,L-Phenylalanine,63-91-2,approved; investigational; nutraceutical,COLNVLDHVKWLRT-QMMMGPOBSA-N,"InChI=1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)/t8-/m0/s1",N[C@@H](CC1=CC=CC=C1)C(O)=O,C9H11NO2,C00079,D00021,6140.0,46505708.0,17295.0,CHEMBL301523,PHE,5910.0,18073.0,COLNVLDHVKWLRT,91,6140.0,Phenylalanine,,COLNVLDHVKWLRT-QMMMGPOBSA-N
DB07599,[(2-AMINO-ALPHA-METHOXYIMINO-4-THIAZOLYLACETYL)AMINO]METHYLBORONIC ACID,,experimental,FMYGJTQJYFMFCR-XGICHPGQSA-N,"InChI=1S/C7H11BN4O4S/c1-16-12-5(4-2-17-7(9)11-4)6(13)10-3-8(14)15/h2,14-15H,3H2,1H3,(H2,9,11)(H,10,13)/b12-5-",CO\N=C(/C(=O)NCB(O)O)C1=CSC(N)=N1,C7H11BN4O4S,,,9600412.0,99444070.0,,CHEMBL227452,CXB,7874552.0,50202234.0,FMYGJTQJYFMFCR,1488,9600412.0,,,FMYGJTQJYFMFCR-XGICHPGQSA-N
DB03068,Zebularine,3690-10-6,experimental,RPQZTTQVRYEKCR-WCTZXXKLSA-N,"InChI=1S/C9H12N2O5/c12-4-5-6(13)7(14)8(16-5)11-3-1-2-10-9(11)15/h1-3,5-8,12-14H,4H2/t5-,6-,7-,8-/m1/s1",OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC=NC1=O,C9H12N2O5,,,100016.0,46504541.0,46938.0,CHEMBL504567,ZE8,90372.0,,RPQZTTQVRYEKCR,2364,100016.0,pyrimidin-2-one beta-ribofuranoside,,RPQZTTQVRYEKCR-WCTZXXKLSA-N
DB03904,Urea,57-13-6,approved; investigational,XSQUKJJJFZCRTK-UHFFFAOYSA-N,"InChI=1S/CH4N2O/c2-1(3)4/h(H4,2,3,4)",NC(N)=O,CH4N2O,C00086,D00023,1176.0,46508687.0,16199.0,CHEMBL985,URE,1143.0,24961.0,XSQUKJJJFZCRTK,311,1176.0,Urea,,XSQUKJJJFZCRTK-UHFFFAOYSA-N
DB03424,Ubenimex,58970-76-6,experimental; investigational,VGGGPCQERPFHOB-RDBSUJKOSA-N,"InChI=1S/C16H24N2O4/c1-10(2)8-13(16(21)22)18-15(20)14(19)12(17)9-11-6-4-3-5-7-11/h3-7,10,12-14,19H,8-9,17H2,1-2H3,(H,18,20)(H,21,22)/t12-,13+,14+/m1/s1",[H][C@@](N)(CC1=CC=CC=C1)[C@]([H])(O)C(O)=N[C@@]([H])(CC(C)C)C(O)=O,C16H24N2O4,,,72172.0,46505598.0,,CHEMBL29292,BES,65145.0,50367209.0,VGGGPCQERPFHOB,1621,3238.0,,,VGGGPCQERPFHOB-UHFFFAOYSA-N
DB08258,6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID,,experimental,KFTVEPYSUSWBRD-UHFFFAOYSA-N,"InChI=1S/C13H24N2O3/c16-12(17)9-5-2-6-10-14-13(18)15-11-7-3-1-4-8-11/h11H,1-10H2,(H,16,17)(H2,14,15,18)",OC(=O)CCCCCNC(=O)NC1CCCCC1,C13H24N2O3,,,6420120.0,99444729.0,,CHEMBL434374,NC6,4925685.0,50192966.0,KFTVEPYSUSWBRD,2569,6420120.0,,,KFTVEPYSUSWBRD-UHFFFAOYSA-N
DB12610,Ebselen,60940-34-3,investigational,DYEFUKCXAQOFHX-UHFFFAOYSA-N,InChI=1S/C13H9NOSe/c15-13-11-8-4-5-9-12(11)16-14(13)10-6-2-1-3-7-10/h1-9H,O=C1N([Se]C2=CC=CC=C12)C1=CC=CC=C1,C13H9NOSe,,,3194.0,347828824.0,77543.0,CHEMBL51085,,3082.0,34233.0,DYEFUKCXAQOFHX,1308,3194.0,ebselen,"Physiological Effects of Drugs;Pharmacologic Actions;Sensory System Agents;Antirheumatic Agents;Anti-Inflammatory Agents;Protective Agents;Central Nervous System Agents;Gastrointestinal Agents;Molecular Mechanisms of Pharmacological Action;Peripheral Nervous System Agents;Therapeutic Uses;Specialty Uses of Chemicals;Anti-Ulcer Agents;Enzyme Inhibitors;Analgesics, Non-Narcotic;Analgesics;Antioxidants;Neuroprotective Agents;Chemical Actions and Uses;Anti-Inflammatory Agents, Non-Steroidal;Cyclooxygenase Inhibitors",DYEFUKCXAQOFHX-UHFFFAOYSA-N
DB08256,N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE,,experimental,NVORCMBCUHQRDL-UHFFFAOYSA-N,"InChI=1S/C9H16N2O3/c12-8(13)6-10-9(14)11-7-4-2-1-3-5-7/h7H,1-6H2,(H,12,13)(H2,10,11,14)",OC(=O)CNC(=O)NC1CCCCC1,C9H16N2O3,,,4149241.0,99444727.0,,CHEMBL66380,NC3,3361505.0,50143914.0,NVORCMBCUHQRDL,2293,4149241.0,,,NVORCMBCUHQRDL-UHFFFAOYSA-N
DB08257,4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID,,experimental,WSVFRGGLURJIMG-UHFFFAOYSA-N,"InChI=1S/C11H20N2O3/c14-10(15)7-4-8-12-11(16)13-9-5-2-1-3-6-9/h9H,1-8H2,(H,14,15)(H2,12,13,16)",OC(=O)CCCNC(=O)NC1CCCCC1,C11H20N2O3,,,6420119.0,99444728.0,,CHEMBL219695,NC4,4925684.0,50192936.0,WSVFRGGLURJIMG,813,6420119.0,,,WSVFRGGLURJIMG-UHFFFAOYSA-N
DB01833,L-2-Amino-4-(Guanidinooxy)Butyric Acid,,experimental,FSBIGDSBMBYOPN-VKHMYHEASA-N,"InChI=1S/C5H12N4O3/c6-3(4(10)11)1-2-12-9-5(7)8/h3H,1-2,6H2,(H,10,11)(H4,7,8,9)/t3-/m0/s1",N[C@@H](CCONC(N)=N)C(O)=O,C5H12N4O3,C00308,,439202.0,46507101.0,609827.0,CHEMBL443732,GGB,388342.0,50370459.0,FSBIGDSBMBYOPN,1238,275.0,,,FSBIGDSBMBYOPN-UHFFFAOYSA-N
DB01835,4r-Fluoro-N6-Ethanimidoyl-L-Lysine,,experimental,LTCJJIZTKXNFGK-RQJHMYQMSA-N,"InChI=1S/C8H16FN3O2/c1-5(10)12-3-2-6(9)4-7(11)8(13)14/h6-7H,2-4,11H2,1H3,(H2,10,12)(H,13,14)/t6-,7+/m1/s1",CC(=N)NCC[C@@H](F)C[C@H](N)C(O)=O,C8H16FN3O2,,,448269.0,46508853.0,,,I58,395122.0,,LTCJJIZTKXNFGK,965,448269.0,,,LTCJJIZTKXNFGK-RQJHMYQMSA-N
DB02061,Cellobiose,528-50-7,experimental,GUBGYTABKSRVRQ-CUHNMECISA-N,"InChI=1S/C12H22O11/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17/h3-20H,1-2H2/t3-,4-,5-,6+,7-,8-,9-,10-,11?,12+/m1/s1",OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O,C12H22O11,C00185,,439178.0,46505046.0,17057.0,,CBI,388323.0,,GUBGYTABKSRVRQ,1944,294.0,Maltose,Food Ingredients;Chemical Actions and Uses;Specialty Uses of Chemicals;Sweetening Agents;Flavoring Agents;Food Additives,GUBGYTABKSRVRQ-UHFFFAOYSA-N
DB03911,L-Xylopyranose,,experimental,SRBFZHDQGSBBOR-CZBDKTQLSA-N,"InChI=1S/C5H10O5/c6-2-1-10-5(9)4(8)3(2)7/h2-9H,1H2/t2-,3+,4-,5?/m0/s1",O[C@H]1COC(O)[C@@H](O)[C@@H]1O,C5H10O5,,,439509.0,46508015.0,59275.0,CHEMBL1374069,LXC,388606.0,,SRBFZHDQGSBBOR,401,229.0,,,SRBFZHDQGSBBOR-UHFFFAOYSA-N
DB03192,3r-Hydroxydecanoyl-Coa,,experimental,HIVSMYZAMUNFKZ-PDQACDDGSA-N,"InChI=1S/C31H54N7O18P3S/c1-4-5-6-7-8-9-19(39)14-22(41)60-13-12-33-21(40)10-11-34-29(44)26(43)31(2,3)16-53-59(50,51)56-58(48,49)52-15-20-25(55-57(45,46)47)24(42)30(54-20)38-18-37-23-27(32)35-17-36-28(23)38/h17-20,24-26,30,39,42-43H,4-16H2,1-3H3,(H,33,40)(H,34,44)(H,48,49)(H,50,51)(H2,32,35,36)(H2,45,46,47)/t19-,20-,24-,25-,26+,30-/m1/s1",[H][C@@](O)(CCCCCCC)CC(=O)SCCN=C(O)CCN=C(O)[C@]([H])(O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(O)=O,C31H54N7O18P3S,,,447877.0,46504729.0,74405.0,,HDC,394845.0,,HIVSMYZAMUNFKZ,2798,440605.0,3-hydroxydecanoyl-coenzyme A,,HIVSMYZAMUNFKZ-FHRNIPIGSA-N
DB03034,D-Levofloxacin,100986-86-5,experimental,GSDSWSVVBLHKDQ-SNVBAGLBSA-N,"InChI=1S/C18H20FN3O4/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)/t10-/m1/s1",C[C@@H]1COC2=C(N3CCN(C)CC3)C(F)=CC3=C2N1C=C(C(O)=O)C3=O,C18H20FN3O4,,,452723.0,46506037.0,,CHEMBL420937,XED,398760.0,,GSDSWSVVBLHKDQ,3773,149096.0,Levofloxacin,"Topoisomerase II Inhibitors;Pharmacologic Actions;Cytochrome P-450 CYP1A2 Inhibitors;Antineoplastic Agents;Anti-Infective Agents, Urinary;Metabolic Side Effects of Drugs and Substances;Molecular Mechanisms of Pharmacological Action;Anti-Bacterial Agents;Cytochrome P-450 Enzyme Inhibitors;Renal Agents;Therapeutic Uses;Chemical Actions and Uses;Topoisomerase Inhibitors;Anti-Infective Agents;Enzyme Inhibitors",GSDSWSVVBLHKDQ-JTQLQIEISA-N
DB01644,"3,6-Dihydroxy-Xanthene-9-Propionic Acid",,experimental,PFQGLFBMMPZYEU-UHFFFAOYSA-N,"InChI=1S/C16H14O5/c17-9-1-3-12-11(5-6-16(19)20)13-4-2-10(18)8-15(13)21-14(12)7-9/h1-4,7-8,11,17-18H,5-6H2,(H,19,20)",OC(=O)CCC1C2=CC=C(O)C=C2OC2=C1C=CC(O)=C2,C16H14O5,,,449159.0,46507003.0,,,HXP,395767.0,,PFQGLFBMMPZYEU,698,449159.0,,,PFQGLFBMMPZYEU-UHFFFAOYSA-N
DB03608,Diminazene,536-71-0,experimental,XNYZHCFCZNMTFY-UHFFFAOYSA-N,"InChI=1S/C14H15N7/c15-13(16)9-1-5-11(6-2-9)19-21-20-12-7-3-10(4-8-12)14(17)18/h1-8H,(H3,15,16)(H3,17,18)(H,19,20)",NC(=N)C1=CC=C(N\N=N\C2=CC=C(C=C2)C(N)=N)C=C1,C14H15N7,C18388,,2354.0,46504758.0,81724.0,CHEMBL35241,BRN,2264.0,50000999.0,XNYZHCFCZNMTFY,2718,2354.0,Diminazene,Antiprotozoal Agents;Pharmacologic Actions;Anti-Infective Agents;Chemical Actions and Uses;Trypanocidal Agents;Antiparasitic Agents;Therapeutic Uses,XNYZHCFCZNMTFY-UHFFFAOYSA-N
DB04062,Beta-D-Fucose,,experimental,SHZGCJCMOBCMKK-FPRJBGLDSA-N,"InChI=1S/C6H12O5/c1-2-3(7)4(8)5(9)6(10)11-2/h2-10H,1H3/t2-,3+,4+,5-,6-/m1/s1",C[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O,C6H12O5,C02095,,439650.0,46508752.0,27442.0,,FCB,388721.0,,SHZGCJCMOBCMKK,23,71315513.0,,,SHZGCJCMOBCMKK-DLABPRKASA-N
DB03485,Alpha-D-Fucose,,experimental,SHZGCJCMOBCMKK-PHYPRBDBSA-N,"InChI=1S/C6H12O5/c1-2-3(7)4(8)5(9)6(10)11-2/h2-10H,1H3/t2-,3+,4+,5-,6+/m1/s1",C[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O,C6H12O5,,,444200.0,46505015.0,42564.0,CHEMBL609880,FCA,392189.0,,SHZGCJCMOBCMKK,23,71315513.0,,,SHZGCJCMOBCMKK-DLABPRKASA-N
DB06851,N-(pyridin-3-ylmethyl)aniline,,experimental,BJXLHKJBRORJJJ-UHFFFAOYSA-N,"InChI=1S/C12H12N2/c1-2-6-12(7-3-1)14-10-11-5-4-8-13-9-11/h1-9,14H,10H2",C(NC1=CC=CC=C1)C1=CC=CN=C1,C12H12N2,,,1082702.0,99443322.0,,CHEMBL264669,11X,923306.0,50294172.0,BJXLHKJBRORJJJ,2965,1082702.0,,,BJXLHKJBRORJJJ-UHFFFAOYSA-N
DB00766,Clavulanic acid,58001-44-8,approved; vet_approved,HZZVJAQRINQKSD-PBFISZAISA-N,"InChI=1S/C8H9NO5/c10-2-1-4-7(8(12)13)9-5(11)3-6(9)14-4/h1,6-7,10H,2-3H2,(H,12,13)/b4-1-/t6-,7-/m1/s1",[H][C@@]12CC(=O)N1[C@@H](C(O)=O)\C(O2)=C\CO,C8H9NO5,C06662,,5280980.0,46508845.0,48947.0,CHEMBL777,J01,4444466.0,50021959.0,HZZVJAQRINQKSD,1440,2172.0,,,HZZVJAQRINQKSD-UHFFFAOYSA-N
DB04368,Bb-3497,235784-88-0,experimental,AVDLWYHBABSSHC-CHWSQXEVSA-N,"InChI=1S/C16H31N3O4/c1-7-8-9-12(10-19(23)11-20)14(21)17-13(16(2,3)4)15(22)18(5)6/h11-13,23H,7-10H2,1-6H3,(H,17,21)/t12-,13-/m1/s1",[H][C@@](CCCC)(CN(O)C=O)C(=O)N[C@]([H])(C(=O)N(C)C)C(C)(C)C,C16H31N3O4,,,159596.0,46504617.0,,CHEMBL431210,BB1,140323.0,50104501.0,AVDLWYHBABSSHC,1216,159596.0,BB3497,,AVDLWYHBABSSHC-CHWSQXEVSA-N
DB07496,"1,3-DIPHENYLUREA",,experimental,GWEHVDNNLFDJLR-UHFFFAOYSA-N,"InChI=1S/C13H12N2O/c16-13(14-11-7-3-1-4-8-11)15-12-9-5-2-6-10-12/h1-10H,(H2,14,15,16)",O=C(NC1=CC=CC=C1)NC1=CC=CC=C1,C13H12N2O,,,7595.0,99443967.0,41320.0,CHEMBL354676,BSU,7314.0,25725.0,GWEHVDNNLFDJLR,2468,7595.0,,,GWEHVDNNLFDJLR-UHFFFAOYSA-N
DB02644,N-Omega-Propyl-L-Arginine,,experimental,AOMXURITGZJPKB-ZETCQYMHSA-O,"InChI=1S/C9H20N4O2/c1-2-5-12-9(11)13-6-3-4-7(10)8(14)15/h7H,2-6,10H2,1H3,(H,14,15)(H3,11,12,13)/p+1/t7-/m0/s1",CCCNC(=[NH2+])NCCC[C@H](N)C(O)=O,C9H21N4O2,,,5287494.0,46507586.0,,,3AR,4449861.0,,AOMXURITGZJPKB,933,4387.0,,,AOMXURITGZJPKB-UHFFFAOYSA-N
DB00266,Dicoumarol,66-76-2,approved,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,"InChI=1S/C19H12O6/c20-16-10-5-1-3-7-14(10)24-18(22)12(16)9-13-17(21)11-6-2-4-8-15(11)25-19(13)23/h1-8,20-21H,9H2",OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC2=C1C=CC=C2,C19H12O6,C00796,D03798,54676038.0,46505536.0,4513.0,CHEMBL1466,,10183330.0,35525.0,DOBMPNYZJYQDGZ,3361,25201794.0,,,DOBMPNYZJYQDGZ-UHFFFAOYSA-L
DB00262,Carmustine,154-93-8,approved; investigational,DLGOEMSEDOSKAD-UHFFFAOYSA-N,"InChI=1S/C5H9Cl2N3O2/c6-1-3-8-5(11)10(9-12)4-2-7/h1-4H2,(H,8,11)",ClCCNC(=O)N(CCCl)N=O,C5H9Cl2N3O2,C06873,D00254,2578.0,46506980.0,3423.0,CHEMBL513,,2480.0,50015950.0,DLGOEMSEDOSKAD,2383,2578.0,Carmustine,"Toxic Actions;Antineoplastic Agents, Alkylating;Pharmacologic Actions;Antineoplastic Agents;Molecular Mechanisms of Pharmacological Action;Noxae;Alkylating Agents;Chemical Actions and Uses;Therapeutic Uses",DLGOEMSEDOSKAD-UHFFFAOYSA-N
DB03305,N5-Iminoethyl-L-Ornithine,,experimental,UYZFAUAYFLEHRC-LURJTMIESA-N,"InChI=1S/C7H15N3O2/c1-5(8)10-4-2-3-6(9)7(11)12/h6H,2-4,9H2,1H3,(H2,8,10)(H,11,12)/t6-/m0/s1",[H][C@](N)(CCCNC(C)=N)C(O)=O,C7H15N3O2,,,107984.0,46507343.0,,CHEMBL11471,ILO,97098.0,50072297.0,UYZFAUAYFLEHRC,1480,107984.0,N(G)-iminoethylornithine,Molecular Mechanisms of Pharmacological Action;Enzyme Inhibitors;Pharmacologic Actions;Chemical Actions and Uses,UYZFAUAYFLEHRC-LURJTMIESA-N
DB05327,Ranirestat,147254-64-6,investigational,QCVNMNYRNIMDKV-QGZVFWFLSA-N,"InChI=1S/C17H11BrFN3O4/c18-10-4-3-9(11(19)6-10)8-21-14(24)12-2-1-5-22(12)17(16(21)26)7-13(23)20-15(17)25/h1-6H,7-8H2,(H,20,23,25)/t17-/m1/s1",FC1=C(CN2C(=O)C3=CC=CN3[C@@]3(CC(=O)NC3=O)C2=O)C=CC(Br)=C1,C17H11BrFN3O4,,,153948.0,175426978.0,,CHEMBL334830,,135685.0,50067407.0,QCVNMNYRNIMDKV,1544,9953887.0,,,QCVNMNYRNIMDKV-UHFFFAOYSA-N
DB02895,3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol,,experimental,HSVQDVSVQIMRSS-CDAZIORVSA-N,"InChI=1S/C6H10OS2/c1-2-5-9(7)6-3-4-8/h2-4,8H,1,5-6H2/b4-3+/t9-/m1/s1",S\C=C\C[S@](=O)CC=C,C6H10OS2,,,9543424.0,46505601.0,,,AJ3,7822391.0,,HSVQDVSVQIMRSS,1193,9543424.0,,,HSVQDVSVQIMRSS-CDAZIORVSA-N
DB03106,scyllo-inositol,488-59-5,investigational,CDAISMWEOUEBRE-CDRYSYESSA-N,"InChI=1S/C6H12O6/c7-1-2(8)4(10)6(12)5(11)3(1)9/h1-12H/t1-,2-,3+,4+,5-,6-",O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,C6H12O6,C06153,,892.0,46505198.0,10642.0,CHEMBL468154,2H3,10254646.0,,CDAISMWEOUEBRE,3092,892.0,scyllitol,,CDAISMWEOUEBRE-UHFFFAOYSA-N
DB02020,Alrestatin,51411-04-2,experimental,GCUCIFQCGJIRNT-UHFFFAOYSA-N,"InChI=1S/C14H9NO4/c16-11(17)7-15-13(18)9-5-1-3-8-4-2-6-10(12(8)9)14(15)19/h1-6H,7H2,(H,16,17)",OC(=O)CN1C(=O)C2=CC=CC3=CC=CC(C1=O)=C23,C14H9NO4,,,2120.0,46508635.0,,CHEMBL63055,ALR,2036.0,16415.0,GCUCIFQCGJIRNT,1773,2120.0,alrestatin,Pharmacologic Actions;Chemical Actions and Uses;Parasympatholytics;Physiological Effects of Drugs;Enzyme Inhibitors;Autonomic Agents;Molecular Mechanisms of Pharmacological Action;Peripheral Nervous System Agents,GCUCIFQCGJIRNT-UHFFFAOYSA-N
DB03411,"2-Hydroxymethyl-Pyrrolidine-3,4-Diol",,experimental,OQEBIHBLFRADNM-YUPRTTJUSA-N,"InChI=1S/C5H11NO3/c7-2-3-5(9)4(8)1-6-3/h3-9H,1-2H2/t3-,4-,5-/m0/s1",OC[C@@H]1NC[C@H](O)[C@H]1O,C5H11NO3,,,127716.0,46504688.0,,CHEMBL406973,EDG,113295.0,50375511.0,OQEBIHBLFRADNM,3257,1335.0,,,OQEBIHBLFRADNM-UHFFFAOYSA-N
DB00848,Levamisole,14769-73-4,approved; investigational; vet_approved; withdrawn,HLFSDGLLUJUHTE-SNVBAGLBSA-N,"InChI=1S/C11H12N2S/c1-2-4-9(5-3-1)10-8-13-6-7-14-11(13)12-10/h1-5,10H,6-8H2/t10-/m1/s1",C1CN2C[C@@H](N=C2S1)C1=CC=CC=C1,C11H12N2S,C07070,D08114,26879.0,46509052.0,6432.0,CHEMBL1454,,25037.0,50241179.0,HLFSDGLLUJUHTE,391,26879.0,Levamisole,"Antirheumatic Agents;Antinematodal Agents;Immunologic Factors;Anti-Infective Agents;Adjuvants, Immunologic;Antiparasitic Agents;Therapeutic Uses;Pharmacologic Actions;Chemical Actions and Uses;Physiological Effects of Drugs;Anthelmintics",HLFSDGLLUJUHTE-SNVBAGLBSA-N
DB03640,Beta-Hydroxyaspartic Acid,,experimental,YYLQUHNPNCGKJQ-NHYDCYSISA-N,"InChI=1S/C4H7NO5/c5-1(3(7)8)2(6)4(9)10/h1-2,6H,5H2,(H,7,8)(H,9,10)/t1-,2+/m0/s1",N[C@@H]([C@@H](O)C(O)=O)C(O)=O,C4H7NO5,C03961,,14463.0,46508333.0,17576.0,CHEMBL3317781,BH2,13809.0,,YYLQUHNPNCGKJQ,3346,5425.0,3-hydroxyaspartic acid,,YYLQUHNPNCGKJQ-UHFFFAOYSA-N
DB02731,Ethylmercurithiosalicylic acid,148-61-8,experimental,HXQVQGWHFRNKMS-UHFFFAOYSA-M,"InChI=1S/C7H6O2S.C2H5.Hg/c8-7(9)5-3-1-2-4-6(5)10;1-2;/h1-4,10H,(H,8,9);1H2,2H3;/q;;+1/p-1",CC[Hg]SC1=CC=CC=C1C(O)=O,C9H10HgO2S,,,67361.0,46506518.0,33214.0,,EMT,60691.0,50366032.0,HXQVQGWHFRNKMS,1110,67361.0,,,HXQVQGWHFRNKMS-UHFFFAOYSA-M
DB03138,Perchlorate,14797-73-0,experimental,VLTRZXGMWDSKGL-UHFFFAOYSA-M,"InChI=1S/ClHO4/c2-1(3,4)5/h(H,2,3,4,5)/p-1",[O-][Cl](=O)(=O)=O,ClO4,,,123351.0,46506970.0,49706.0,,LCP,109953.0,36131.0,VLTRZXGMWDSKGL,292,24247.0,Perchloric Acid,,VLTRZXGMWDSKGL-UHFFFAOYSA-N
DB01190,Clindamycin,18323-44-9,approved; vet_approved,KDLRVYVGXIQJDK-NOWPCOIGSA-N,"InChI=1S/C18H33ClN2O5S/c1-5-6-10-7-11(21(3)8-10)17(25)20-12(9(2)19)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,22-24H,5-8H2,1-4H3,(H,20,25)/t9?,10-,11+,12?,13+,14-,15-,16-,18-/m1/s1",CCC[C@@H]1C[C@H](N(C)C1)C(=O)NC(C(C)Cl)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O,C18H33ClN2O5S,C06914,D00277,446598.0,46506073.0,3745.0,CHEMBL376185,CLY,27005.0,,KDLRVYVGXIQJDK,12,29029.0,Clindamycin,Enzyme Inhibitors;Anti-Infective Agents;Pharmacologic Actions;Molecular Mechanisms of Pharmacological Action;Anti-Bacterial Agents;Chemical Actions and Uses;Protein Synthesis Inhibitors;Therapeutic Uses,KDLRVYVGXIQJDK-NOWPCOIGSA-N
DB06894,1-DODECANOL,,experimental,LQZZUXJYWNFBMV-UHFFFAOYSA-N,"InChI=1S/C12H26O/c1-2-3-4-5-6-7-8-9-10-11-12-13/h13H,2-12H2,1H3",CCCCCCCCCCCCO,C12H26O,C02277,,8193.0,99443365.0,28878.0,CHEMBL24722,1DO,7901.0,,LQZZUXJYWNFBMV,3164,8193.0,Dodecanol,,LQZZUXJYWNFBMV-UHFFFAOYSA-N
DB04106,Fotemustine,,experimental; investigational,YAKWPXVTIGTRJH-QMMMGPOBSA-N,"InChI=1S/C9H19ClN3O5P/c1-4-17-19(16,18-5-2)8(3)11-9(14)13(12-15)7-6-10/h8H,4-7H2,1-3H3,(H,11,14)/t8-/m0/s1",CCOP(=O)(OCC)[C@@H](C)NC(=O)N(CCCl)N=O,C9H19ClN3O5P,,,46936889.0,46505097.0,131854.0,,,26330202.0,,YAKWPXVTIGTRJH,1665,104799.0,fotemustine,Chemical Actions and Uses;Antineoplastic Agents;Therapeutic Uses;Pharmacologic Actions,YAKWPXVTIGTRJH-UHFFFAOYSA-N
DB07450,(R)-minalrestat,,experimental,BMHZAHGTGIZZCT-LJQANCHMSA-N,"InChI=1S/C19H11BrF2N2O4/c20-10-2-1-9(14(22)5-10)8-24-16(26)12-4-3-11(21)6-13(12)19(18(24)28)7-15(25)23-17(19)27/h1-6H,7-8H2,(H,23,25,27)/t19-/m1/s1",[H]N1C(=O)C[C@@]2(C1=O)C(=O)N(CC1=C(F)C=C(Br)C=C1)C(=O)C1=C2C=C(F)C=C1,C19H11BrF2N2O4,,,447950.0,99443921.0,,CHEMBL292963,BFI,394897.0,50038843.0,BMHZAHGTGIZZCT,3754,190816.0,minalrestat,,BMHZAHGTGIZZCT-UHFFFAOYSA-N
DB08084,IDD594,,experimental,JCZUIWYXULSXSW-UHFFFAOYSA-N,"InChI=1S/C16H12BrF2NO3S/c17-10-2-1-9(13(19)5-10)7-20-16(24)12-4-3-11(18)6-14(12)23-8-15(21)22/h1-6H,7-8H2,(H,20,24)(H,21,22)",OC(=O)COC1=CC(F)=CC=C1C(=S)NCC1=CC=C(Br)C=C1F,C16H12BrF2NO3S,,,4369325.0,99444555.0,,CHEMBL395347,LDT,3571927.0,16313.0,JCZUIWYXULSXSW,1575,4369325.0,Idd 594,,JCZUIWYXULSXSW-UHFFFAOYSA-N
DB01124,Tolbutamide,64-77-7,approved; investigational,JLRGJRBPOGGCBT-UHFFFAOYSA-N,"InChI=1S/C12H18N2O3S/c1-3-4-9-13-12(15)14-18(16,17)11-7-5-10(2)6-8-11/h5-8H,3-4,9H2,1-2H3,(H2,13,14,15)",CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1,C12H18N2O3S,C07148,D00380,5505.0,46508421.0,27999.0,CHEMBL782,,5304.0,50027886.0,JLRGJRBPOGGCBT,1902,5505.0,Tolbutamide,Physiological Effects of Drugs;Chemical Actions and Uses;Hypoglycemic Agents;Pharmacologic Actions,JLRGJRBPOGGCBT-UHFFFAOYSA-N
DB01120,Gliclazide,21187-98-4,approved,BOVGTQGAOIONJV-UHFFFAOYSA-N,"InChI=1S/C15H21N3O3S/c1-11-5-7-14(8-6-11)22(20,21)17-15(19)16-18-9-12-3-2-4-13(12)10-18/h5-8,12-13H,2-4,9-10H2,1H3,(H2,16,17,19)",CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CC2CCCC2C1,C15H21N3O3S,,D01599,3475.0,46505475.0,31654.0,CHEMBL427216,,3356.0,50103512.0,BOVGTQGAOIONJV,2228,3475.0,Gliclazide,Pharmacologic Actions;Physiological Effects of Drugs;Chemical Actions and Uses;Hypoglycemic Agents,BOVGTQGAOIONJV-UHFFFAOYSA-N
DB01683,Chymostatin,9076-44-2,experimental,MRXDGVXSWIXTQL-LROMGURASA-N,"InChI=1S/C31H41N7O6/c1-19(2)15-24(27(40)34-22(18-39)16-20-9-5-3-6-10-20)35-28(41)26(23-13-14-33-30(32)36-23)38-31(44)37-25(29(42)43)17-21-11-7-4-8-12-21/h3-12,18-19,22-26H,13-17H2,1-2H3,(H,34,40)(H,35,41)(H,42,43)(H3,32,33,36)(H2,37,38,44)/t22-,23-,24-,25-,26-/m0/s1",[H][C@](CC1=CC=CC=C1)(C=O)N=C(O)[C@]([H])(CC(C)C)N=C(O)[C@@]([H])(NC(O)=N[C@@]([H])(CC1=CC=CC=C1)C(O)=O)[C@]1([H])CCNC(=N)N1,C31H41N7O6,C11308,,5287931.0,46507872.0,,,,4450198.0,50210112.0,MRXDGVXSWIXTQL,532,443119.0,chymostatin,Serine Proteinase Inhibitors;Protease Inhibitors;Enzyme Inhibitors;Molecular Mechanisms of Pharmacological Action;Chemical Actions and Uses;Pharmacologic Actions,MRXDGVXSWIXTQL-HYHFHBMOSA-N
DB04253,Tretazicar,21919-05-1,investigational,WOCXQMCIOTUMJV-UHFFFAOYSA-N,"InChI=1S/C9H8N4O5/c10-9(14)5-3-7(11-1-2-11)8(13(17)18)4-6(5)12(15)16/h3-4H,1-2H2,(H2,10,14)",NC(=O)C1=CC(N2CC2)=C(C=C1[N+]([O-])=O)[N+]([O-])=O,C9H8N4O5,,,89105.0,46509068.0,,CHEMBL23330,CB1,80403.0,50004681.0,WOCXQMCIOTUMJV,3738,89105.0,tretazicar,Chemical Actions and Uses;Therapeutic Uses;Radiation-Sensitizing Agents;Antineoplastic Agents;Pharmacologic Actions,WOCXQMCIOTUMJV-UHFFFAOYSA-N
DB02518,N-Acetylalanine,97-69-8,experimental,KTHDTJVBEPMMGL-VKHMYHEASA-N,"InChI=1S/C5H9NO3/c1-3(5(8)9)6-4(2)7/h3H,1-2H3,(H,6,7)(H,8,9)/t3-/m0/s1",C[C@H](NC(C)=O)C(O)=O,C5H9NO3,,,88064.0,46504953.0,40992.0,,AYA,79449.0,,KTHDTJVBEPMMGL,2880,7345.0,N-acetylalanine,,KTHDTJVBEPMMGL-UHFFFAOYSA-N
DB02101,"(S,R)-fidarestat",,experimental,WAAPEIZFCHNLKK-QPUJVOFHSA-N,"InChI=1S/C12H10FN3O4/c13-5-1-2-7-6(3-5)12(4-8(20-7)9(14)17)10(18)15-11(19)16-12/h1-3,8H,4H2,(H2,14,17)(H2,15,16,18,19)/t8-,12+/m0/s1",[H][C@]1(C[C@@]2(N=C(O)N=C2O)C2=C(O1)C=CC(F)=C2)C(O)=N,C12H10FN3O4,,,449157.0,46506217.0,,CHEMBL189464,FIS,395766.0,50151407.0,WAAPEIZFCHNLKK,25,3349.0,,,WAAPEIZFCHNLKK-UHFFFAOYSA-N
DB12731,Daporinad,658084-64-1,investigational,KPBNHDGDUADAGP-VAWYXSNFSA-N,"InChI=1S/C24H29N3O2/c28-23(12-11-21-8-6-15-25-19-21)26-16-5-4-7-20-13-17-27(18-14-20)24(29)22-9-2-1-3-10-22/h1-3,6,8-12,15,19-20H,4-5,7,13-14,16-18H2,(H,26,28)/b12-11+",O=C(NCCCCC1CCN(CC1)C(=O)C1=CC=CC=C1)\C=C\C1=CC=CN=C1,C24H29N3O2,,,6914657.0,347828925.0,,CHEMBL566757,DGB,5290535.0,81395.0,KPBNHDGDUADAGP,985,6914657.0,N-(4-(1-benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide,,KPBNHDGDUADAGP-VAWYXSNFSA-N
DB00806,Pentoxifylline,6493-05-6,approved; investigational,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,"InChI=1S/C13H18N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8H,4-7H2,1-3H3",CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C,C13H18N4O3,C07424,D00501,4740.0,46505940.0,7986.0,CHEMBL628,PNX,4578.0,10850.0,BYPFEZZEUUWMEJ,2305,4740.0,Pentoxifylline,Specialty Uses of Chemicals;Hematologic Agents;Enzyme Inhibitors;Protective Agents;Platelet Aggregation Inhibitors;Phosphodiesterase Inhibitors;Radiation-Protective Agents;Physiological Effects of Drugs;Antioxidants;Chemical Actions and Uses;Therapeutic Uses;Cardiovascular Agents;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Free Radical Scavengers;Vasodilator Agents,BYPFEZZEUUWMEJ-UHFFFAOYSA-N
DB07778,FAMOXADONE,,experimental,PCCSBWNGDMYFCW-QFIPXVFZSA-N,"InChI=1S/C22H18N2O4/c1-22(16-12-14-19(15-13-16)27-18-10-6-3-7-11-18)20(25)24(21(26)28-22)23-17-8-4-2-5-9-17/h2-15,23H,1H3/t22-/m0/s1",C[C@]1(OC(=O)N(NC2=CC=CC=C2)C1=O)C1=CC=C(OC2=CC=CC=C2)C=C1,C22H18N2O4,,,446845.0,99444249.0,106738.0,CHEMBL10118,FMX,394094.0,,PCCSBWNGDMYFCW,726,213032.0,famoxadone,,PCCSBWNGDMYFCW-UHFFFAOYSA-N
